http___www.kardio.hr_home_strucni-clanci_311-prehrana-kod-metabolickog-sindroma.html_1.xml
1.1 2.1 3.1 4.1 5.1 6.1 7.1 8.1 9.1 10.1 11.1 12.1 13.1 14.1 15.1 16.1 17.1 18.1 19.1 21.1 22.1 23.1 24.1 25.1 26.1 26.2 27.1 28.1 28.2 28.3 28.4 28.5 28.6 28.7 28.8 29.1 30.1 31.1 31.2 31.3 31.4 31.5 31.6 31.7 31.8 31.9 32.1 33.1 34.1 34.2 34.3 34.4 34.5 34.6 35.1 36.1 36.2 37.1 38.1 38.2 38.3 38.4 39.1 39.2 39.3 39.4 39.5 39.6 39.7 39.8 39.9 40.1 40.2 40.3 40.4 41.1 42.1 42.2 43.1 44.1 44.2 44.3 44.4 44.5 44.6 45.1 46.1 46.2 46.3 46.4 46.5 46.6 47.1 48.1 48.2 48.3 48.4 48.5 49.1 50.1 50.2 50.3 50.4 50.5 51.1 51.2 51.3 52.1 52.2 52.3 52.4 52.5 52.6 53.1 53.2 53.3 54.1 55.1 55.2 55.3 56.1 57.1 57.2 57.3 57.4 57.5 57.6 58.1 59.1 59.2 59.3 59.4 60.1 61.1 61.2 61.3 61.4 62.1 62.2 62.3 62.4 62.5 62.6 62.7 62.8 63.1 63.2 63.3 64.1 64.2 64.3 64.4 64.5 65.1 65.2 65.3 65.4 66.1 66.2 66.3 66.4 67.1 67.2 67.3 67.4 67.5 68.1 69.1 69.2 69.3 69.4 69.5 69.6 69.7 69.8 69.9 69.10 69.11 69.12 69.13 70.1 71.1 71.2 71.3 72.1 72.2 72.3 72.4 72.5 72.6 73.1 73.2 73.3 73.4 73.5 73.6 73.7 74.1 74.2 74.3 74.4 74.5 74.6 75.1 75.2 75.3 76.1 77.1 77.2 77.3 77.4 77.5 78.1 79.1 79.2 79.3 79.4 79.5 80.1 81.1 81.2 82.1 82.2 82.3 82.4 83.1 84.1 84.2 85.1 85.2 85.3 85.4 85.5 85.6 86.1 86.2 86.3 87.1 87.2 87.3 87.4 87.5 87.6 87.7 87.8 87.9 88.1 88.2 88.3 88.4 88.5 88.6 89.1 89.2 89.3 89.4 89.5 89.6 90.1 91.1 91.2 91.3 91.4 91.5 91.6 91.7 91.8 91.9 92.1 93.1 94.1 95.1 95.2 96.1 96.2 97.1 97.2 98.1 98.2 99.1 100.1 100.2 101.1 101.2 102.1 102.2 103.1 103.2 103.3 104.1 104.2 105.1 106.1 106.2 107.1 107.2 108.1 108.2 108.3 109.1 109.2 110.1 110.2 110.3 111.1 111.2 112.1 112.2 113.1 113.2 113.3 114.1 114.2 114.3 115.1 115.2 116.1 117.1 117.2 118.1 118.2 119.1 119.2 120.1 120.2 121.1 121.2 122.1 122.2 123.1 123.2 124.1 124.2 125.1 125.2 126.1 126.2 127.1 127.2 128.1 128.2 129.1 130.1 131.1 131.2 132.1 132.2 132.3 133.1 133.2 134.1 134.2 135.1 135.2 136.1 136.2 137.1 137.2 138.1 138.2 139.1 139.2 140.1 140.2 141.1 141.2 142.1 142.2 143.1 143.2 144.1 144.2 145.1 145.2 146.1 146.2 147.1 147.2 148.1 148.2 149.1 149.2 150.1 150.2 151.1 151.2 152.1 152.2 153.1 153.2 154.1 154.2 154.3 155.1 155.2 156.1 156.2 157.1 157.2 158.1 158.2 159.1 159.2 160.1 160.2 161.1 161.2 162.1 162.2 163.1 163.2 164.1 164.2 165.1 165.2 166.1 166.2 167.1 167.2 168.1 168.2 169.1 169.2 170.1 170.2 171.1 171.2 171.3 172.1 172.2 173.1 173.2 174.1 174.2 175.1 175.2 176.1 176.2 177.1 177.2 178.1 178.2 178.3 179.1 180.1 180.2 181.1 181.2 182.1 182.2 183.1 183.2 184.1 184.2 185.1 185.2 186.1 186.2 187.1 187.2 188.1 188.2 188.3 189.1 189.2 190.1 190.2 191.1 191.2 192.1 192.2 193.1 193.2 194.1 194.2 195.1 195.2 196.1 196.2 197.1 197.2 198.1 198.2 199.1 199.2 200.1 200.2 201.1 201.2 202.1 202.2 203.1 203.2 203.3 204.1 204.2 205.1 205.2 206.1 206.2 207.1 207.2 208.1 209.1 209.2 210.1 210.2 211.1 211.2 212.1 212.2 213.1 213.2 214.1 214.2 215.1 215.2 216.1 216.2 217.1 217.2 217.3 218.1 219.1 219.2 220.1 220.2 221.1 221.2 222.1 222.2 222.3 223.1 223.2 224.1 224.2 225.1 225.2 226.1 226.2 227.1 227.2 228.1 228.2 229.1 229.2 230.1 230.2 231.1 231.2 232.1 232.2 233.1 233.2 234.1 234.2 235.1 235.2 236.1 236.2 237.1 237.2 238.1 238.2 239.1 239.2 239.3 240.1 240.2 241.1 241.2 242.1 242.2 243.1 243.2 244.1 244.2 245.1 245.2 246.1 246.2 247.1 247.2 248.1 248.2 248.3 249.1 250.1 250.2 251.1 251.2 252.1 252.2 253.1 253.2 254.1 254.2 255.1 255.2 256.1 256.2 257.1 257.2 258.1 258.2 259.1 259.2 260.1 260.2 261.1 261.2 262.1 262.2 263.1 263.2 264.1 264.2 265.1 265.2 266.1 266.2 267.1 267.2 268.1 268.2 269.1 269.2 270.1 270.2 271.1 271.2 272.1 272.2 273.1 273.2 274.1 274.2 275.1 275.2 276.1 276.2 277.1 277.2 278.1 278.2
- About this Journal · - Abstracting and Indexing · - Aims and Scope · - Article Processing Charges · - Articles in Press · - Author Guidelines · - Bibliographic Information · - Citations to this Journal · - Contact Information · - Editorial Board · - Editorial Workflow · - Free eTOC Alerts · - Publication Ethics · - Reviewers Acknowledgment · - Submit a Manuscript · - Subscription Information · - Table of Contents Scientifica Volume 2012 (2012), Article ID 424780, 15 pages Nutritional Modulation of Insulin Resistance 1Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism, University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV2 2DX, UK 2Division of Metabolic and Vascular Health, Warwick Medical School, The University of Warwick, Coventry CV4 7AL, UK Received 13 August 2012; Accepted 2 September 2012 Academic Editors: R. Laybutt and S. Samman Copyright © 2012 Martin O. Weickert. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Insulin resistance has been proposed as the strongest single predictor for the development of Type 2 Diabetes (T2DM). Chronic oversupply of energy from food, together with inadequate physical activity, have been recognized as the most relevant factors leading to overweight, abdominal adiposity, insulin resistance, and finally T2DM. Conversely, energy reduced diets almost invariably to facilitate weight loss and reduce abdominal fat mass and insulin resistance. However, sustained weight loss is generally difficult to achieve, and distinct metabolic characteristics in patients with T2DM further compromise success. Therefore, investigating the effects of modulating the macronutrient composition of isoenergetic diets is an interesting concept that may lead to additional important insights. Metabolic effects of various different dietary concepts and strategies have been claimed, but results from randomized controlled studies and particularly from longer-term-controlled interventions in humans are often lacking. However, some of these concepts are supported by recent research, at least in animal models and short-term studies in humans. This paper provides an update of the current literature regarding the role of nutrition in the modulation of insulin resistance, which includes the discussion of weight-loss-independent metabolic effects of commonly used dietary concepts. Introduction Western diseases are epidemic following major changes in lifestyle including physical activity, and the replacement of the traditional high-fiber diet by a diet rich in fat, sugar and protein at the beginning of the 20th century [1–6]. One in three Americans born in 2000 or later and some 50% of members of high-risk ethnic populations are expected to develop type 2 diabetes (T2DM) [7], with all its known negative consequences including renal failure, cardiovascular disease, blindness, neuropathy, amputations, arthritis, obstructive sleep apnoea syndrome, psychological ill health, and premature mortality [8]. It is undisputed that chronic overconsumption of energy in the absence of adequate physical activity leads to weight gain and excess intraabdominal fat, factors that strongly predispose to insulin resistance [9], and finally the development of T2DM [10, 11]. Appropriate dietary measures as part of a healthy lifestyle are known to substantially reduce these risks. Given that loss of excess body weight and reduction of the intraabdominal fat mass are strongly linked with improved insulin sensitivity [9], any energy reduced and safe diet that can be sustained in the long term may be used for both prevention and treatment of insulin resistance, particularly in high-risk subjects. However, sustained weight loss with any dietary strategy is difficult to achieve. Therefore, apart from weight loss and reduction of abdominal fat mass, lifestyle measures that are aimed to improve or prevent insulin sensitivity independent of weight loss are of interest. Evidence is increasing that isoenergetic changes in the quality of ingested foods and in the macronutrient composition of the diet appear to exert additional important effects on insulin sensitivity [12–15], with protective, neutral, or adverse effects of specific foods [6, 16–18]. However, most of the available data so far is derived from in vitro and animal studies, epidemiological studies that do not allow commenting on causality, or from relatively small and short-term intervention studies in humans. Therefore, many of the currently proposed beneficial dietary strategies remain controversial both regarding their safety and efficiency for preventing insulin resistance and T2DM in the long term. This paper reviews current concepts and controversies regarding the modulation of insulin resistance, glucose metabolism, and diabetes risk using dietary measures. Methods This is a narrative review. PubMed was searched for original papers and review articles up to July 2012, with a combination of query terms that included “insulin resistance,” “type 2 diabetes,” “diet,” “nutrition,” “metabolic syndrome,” “dyslipidemia,” “adipokines,” “gut hormones,” “pro-inflammatory factors,” “obesity,” and many others that were assumed to be relevant. Relevant articles were further selected among references in published papers. Using these search criteria, more than 1000 relevant original papers and review articles were identified. Studies and review articles that were assumed to be relevant for covering the respective areas were then hand selected, and articles that did not report substantially different outcomes as compared with the selected ones were excluded. When data from larger trials were available, studies with small sample sizes were excluded, as well as studies that did not report results from a control group, and studies that showed high losses to followup and/or differential losses between the comparison groups. Recommendations in Current Guidelines Nutritional recommendations for the treatment of patients with T2DM and subjects at high risk of developing diabetes [19] generally recommend weight loss of at least 7% in overweight/obese patients; restriction of the intake of saturated fats to <7% of energy intake; a cholesterol intake <200 mg/day; restriction of trans fat intake; a high-fiber intake of at least 14 g/1000 kcal; in newer guidelines, lifted restrictions of protein intake, for example, protein intake of 15–20% of energy as long as kidney function is normal [19]. It is also assumed that the use of low glycemic index (GI) and glycemic load (GL) carbohydrates may provide a modest additional benefit for glycemic control over that observed when total carbohydrate is considered alone [19], and, because of lack of evidence of efficacy and increasing concerns related to long-term safety, discouragement of routine supplementation with antioxidants, such as vitamins E, C, and carotene [19, 20]. Effects of Weight Loss on Insulin Resistance and Diabetes Risk Accumulation of intraabdominal fat mass is the most important cause of insulin resistance and T2DM. Simply being overweight (BMI > 25 kg/m2) raises the risk of developing T2DM by a factor of 3 [21]. It is known since decades that this effect can be effectively reversed by reduction of excess body weight [22]; in obese patients with poorly controlled T2DM even modest weight loss, if maintained, markedly reduces plasma glucose concentrations and improves markers of glucose metabolism [23–25]. Therefore, the recommendation to lose weight remains one of the key principles in the treatment of patients with T2DM [26]. However, even in the general overweight population sustained weight loss is difficult to achieve. Generally, in obese individuals energy expenditure begins to drop as soon as body weight starts to decline [27–29], and powerful hypothalamic hormonal responses are induced in an effort to maintain weight [27]. In addition to this, patients with diabetes appear to face further drawbacks for maintained success. Proposed factors include increased energy expenditure in the hyperglycemic state due to increased protein turnover that may drop toward normal after improvement of glycemic control [27, 30, 31] and reduced loss of the energy carrier glucose with the urine once glucose metabolism improves, resulting in retention of energy that may further contribute to weight regain if energy intake does not drop further [27]. Furthermore, many obese patients with T2DM are typically sedentary and may have relevant barriers to exercising, including neuropathy, foot ulcers, heart disease [27], and anxiousness to experience hypoglycemia. Another problem is medication with certain antidiabetic drugs that are known to cause weight gain such as insulin, sulfonylureas, and thiazolidinediones [27], further compromising the efforts to lose weight in these patients. Reflecting this, the typical weight loss trial in patients with T2DM either shows no relevant weight loss [32], or jojoing with an initially successful weight loss followed by a plateau after 4–6 months and subsequent weight regain [27]. Further complicating this issue is the observation fat mass is regained to a greater degree than is lean mass in those who do experience weight regain after initial weight loss [33]. As an example, when investigating the body composition in postmenopausal women after intentional weight loss, followed by weight regain, for every 1 kg fat lost during weight-loss intervention, 0.26 kg lean tissue was lost, but for every 1 kg fat regained over the following year, only 0.12 kg lean tissue was regained [33]. In addition, relevant exercise levels that would help to lose weight are difficult to achieve. Typically recommended exercise levels that are probably sufficient to improve glycemic control and cardiovascular risk (e.g., 150 min/week of brisk walking) are usually inefficient to achieve relevant weight loss [34]. The optimal volume of exercise to achieve sustained major weight loss appears to be much larger, requiring some 60 min/day or more when relying on exercise alone as a weight loss strategy [8, 34]. The combination of these factors likely contributes to the fact that aiming to achieve and maintain relevant weight loss with the recommendation of energy reduced diets and increased exercise levels often fails in overweight/obese patients with T2DM. Effects of Diets Varying the Macronutrient Composition on Weight Loss The only moderate effects of low fat diets on weight reduction [35] have led to a renaissance of various alternative dietary concepts, including food combining strategies, low-carbohydrate diets that are often high in dietary protein, high-fiber diets, and carbohydrate-rich diets that are aimed at modulating the postprandial glucose and insulin responses and as such the glycemic index (GI) of foods. Some of the most commonly used concepts are discussed in this paper. Effects of Low-Fat Diets on Weight Loss Short-term dietary intervention studies show that low-fat diets lead to weight loss in overweight individuals [36]. However, it is less clear whether a reduction in fat intake is more efficacious than other dietary restrictions in the long term. Fat-restricted diets appear to have no advantages compared with other calorie-restricted diets in achieving long-term weight loss in overweight or obese people. In some analyses participants lost slightly more weight on the control diets but this difference was small and not significantly different from the weight loss achieved through dietary fat restriction [37]. A major problem is poor adherence to low fat diets in the longer term, which appears to be particularly challenging in insulin-resistant subjects [38]. Low-carbohydrate, nonenergy-restricted diets appear to be at least as effective as low-fat, energy-restricted diets in inducing weight loss for up to 1 year [39]. Effects of High-Fiber Diets on Weight Loss A high-fiber intake is emphasized in the recommendations of most nutritional and diabetes associations. Factors that are assumed to contribute to the beneficial effects of fiber intake include the bulking effect of adding low-energy food to the diet, and the slowing of gastric emptying and absorption of dietary carbohydrate and fat contents, a concept that is mainly attributed to viscous water soluble types of dietary fiber [15]. It is also assumed that dietary fiber intake increases satiety and beneficially influences efforts to lose weight [15]. Ludwig has shown that weight gain over a 10-year period correlated better with fiber intake than with the intake of dietary fat contents [40]. However, many other studies reported only moderate effects of fiber intake on weight loss, with no clear differences between the sort of fiber consumed [41], and data from published studies are in part inconclusive [35, 42]. Only few controlled studies investigated the effects of whole grain products on weight loss [43]. Effects of Low Glycemic Index (GI) Diets on Weight Loss In a meta-analysis of six small studies (total number of participants ) with short duration (5 weeks to 6 month), overweight or obese people on low glycemic index (GI) diets lost more weight and had better improvement in lipid profiles than those receiving other diets [44]. Furthermore, in studies comparing low-GI diets with conventional-restricted energy low-fat diets, participants fared at least on the low-GI diets as well, even though total energy intake was ad libitum [44]. However, other studies have shown no advantage of a low versus a high GI diets regarding weight loss [45]. In one of the largest intervention studies published to date, weight regain at 1 year was only marginally lower with a reduction of the GI [46]. Generally, the small number of participants and the relative short duration of the available studies do not allow final conclusions regarding the effect of low-GI diets as a weight loss instrument. Effects of Low-Carbohydrate High-Protein Diets on Weight Loss Energy-reduced diets are difficult to follow because they often require elimination of certain foods, leading to poor adherence and limited success. Increasing the protein content of the diet has been shown to be more successful in achieving weight loss, in comparison to low fat diets, at least in the short term [35, 47]. The most common concept includes carbohydrate restriction and increasing the intake of dietary protein. It is not entirely clear whether low-carbohydrate diets work mainly via increasing the protein content of the diet, or whether reduced carbohydrate intake per se, increased fat intake, or a combination of these factors are the key principles. However, some studies indicate that increasing the protein content of the diet alone, without restricting carbohydrate intake, leads to significantly reduced appetite and energy intake, followed by weight loss and reduction of fat mass, although the small sample size of the study (), the relatively short duration (12 weeks), and the lack of a control group need to be mentioned [48]. Very high-protein diets (protein > 30–35% of energy) with a reduction in both dietary carbohydrate and fat content have been also proposed, but these are difficult to achieve and maintain in daily life without the use of dietary supplements. The same is true for very low-carbohydrate diets, with poor adherence rates even under controlled conditions in dietary intervention studies [49, 50]. More importantly, there are reports indicating that extreme changes in the diet such as very low-carbohydrate diets may have serious adverse effects on health [51]. Moderately low-carbohydrate high-protein diets are attractive because they promise rapid weight loss without having to count calories, and the consumption of many palatable foods is not restricted [35]. These diets also appear to have beneficial effects on blood lipids, body composition, and weight loss, at least in the short term [47]. Better weight loss with low-carbohydrate diets may be explained by higher satiating properties of dietary protein in comparison to other macronutrients, an effect that has been shown both in short- [52–56] and long-term [57, 58] studies. Further factors involved may include a reduced variety of allowed foods, and an aversion against dietary fat content in the absence of relevant amounts of carbohydrates [59], whereas the often proposed ketosis is less likely to play a key role in this context [60, 61]. Lowering the percent protein of the diet from 15% to 10% results in higher total energy intake, predominantly from savoury-flavoured foods available between meals [62], reiterating that a higher dietary protein intake may help to reduce energy intake. High-protein intake may further lead to increased thermogenesis, potentially further contributing to favorable effects of these diets on the regulation of body weight [63–65], and there is evidence that high-protein intake reduces fat mass and increases lean mass in overweight and obese subjects [66]. However, long-term adherence to any diet is a key factor for maintained weight loss [67], with many studies indicating that initially successful high-protein intake is often not sustained in the longer term, even in the setting of controlled dietary interventions [49, 50, 68]. Therefore, relevant long-term adherence to these diets with sustained weight loss may be difficult to achieve. More importantly, evidence is accumulating casting doubt on the long-term safety of these diets, with novel data from longer term prospective cohort studies indicating potential adverse effects on both the risk of developing T2DM [69] and cardiovascular risk factors [70]. Effects of Food Combining Strategies Concepts such as food combining are largely proposed in the lay press, but scientific evidence supporting that these are superior to any other energy restricted diet is lacking [71–73]. In a 6-week study investigating energy reduced but isoenergetic food combining diets with balanced diets with comparable macronutrient composition in 54 obese subjects, authors observed no differences in weight loss between groups, but a tendency to less pronounced weight loss and reduction in body fat mass was noted in the food combining group [73]. However, only few controlled studies have compared these concepts. Importance of Adherence to a Specific Diet Various different dietary concepts have been proposed to improve the effects of dietary strategies on weight loss and its metabolic consequences. Interestingly, more important than the choice of a specific diet appears to be the adherence to and, related to this, the long-term sustainability of the chosen strategy. In a study investigating the effectiveness of four currently widely used diets (Weight Watchers, Zone, Atkins, or Ornish) on weight loss, each diet resulted in modestly reduced body weight and improvement of several cardiac risk factors at 1 year. However, overall adherence rates to all four diets was low, whereas increased adherence was associated with significantly greater weight loss and cardiac risk factor reductions for each diet [67]. In agreement with this, energy-reduced diets resulted in clinically meaningful weight loss regardless of the macronutrient composition (fat, protein or carbohydrates) in a 2-year study in 811 overweight adults. All diets showed comparable effects on feelings of satiety and hunger, satisfaction with the diet, and attendance rates at group sessions, whereas attendance of instructional sessions was strongly associated with weight loss (0.2 kg per session attended), further indicating that adherence to any chosen diet may be a crucial factor and may be more relevant than the macronutrient composition of the diet per se [74]. Dietary Concepts Using Modulation of Macronutrient Composition without Energy Restriction Although weight loss and reduction of abdominal fat mass in patients with T2DM are powerful tools for reducing insulin resistance in principle, sustained relevant weight loss in these patients appears to be difficult to achieve. An increasing number of studies indicate that isoenergetic changes in the macronutrient composition and the quality of ingested foods may exert additional important effects on insulin sensitivity, independent of weight loss. Therefore, it seems reasonable to explore specific metabolic effects of different (isoenergetic) foods and macronutrients on insulin sensitivity both in patients with T2DM and in individuals who are at high risk of developing T2DM [12–15]. Some of the potentially involved concepts and controversies are depicted in Figure 1. Metabolic Effects of the Modulation of Dietary Fat Contents An excessive intake of total fat (>37% of daily energy intake) reduces insulin sensitivity irrespective of the composition of fatty acids (FA) in the diet [14]. Involved factors, apart from excessive energy intake and weight gain, may include impaired glucose transport, decreased binding of insulin to its receptors, and accumulation of stored triacylglycerols in skeletal muscle [14, 75–77]. Therefore, reducing the intake of excess fat from a diet is assumed to be beneficial. However, many overweight/obese patients have difficulties adhering to these diets particularly in the longer term, resulting in only limited success. Although not fat-restricted, Mediterranean style diets exert relevant beneficial effects on insulin resistance, diabetes risk, and cardiovascular health [12, 13], indicating that the type and composition of dietary fat are likely to be important. Especially under conditions of a more moderate fat intake (<30%) different types of dietary fat appear to have a relevant role in the modulation of diet-induced insulin resistance [78]. Dietary fat is a heterogeneous mixture of different FA, with monounsaturated (MUFA), polyunsaturated (PUFA), saturated fatty acids (SFA), and trans unsaturated fatty acids (TFA) as the main components [14]. The adverse effects of TFA on cardiovascular disease are well established but their role in the development of IR and T2DM is less clear [13]. A high intake of TFA may lead to insulin resistance and show adverse effects on cardiovascular disease [13, 79, 80]. Studies in rats have shown that TFA induces insulin resistance both when compared with low fat diets [81] and diets rich in SFA [82, 83]. Moreover, adverse effects of TFA intake on insulin sensitivity may be greater in individuals more predisposed to insulin resistance [84]. In the Nurses’ Health Study, a dose-dependent association between TFA intake and risk of T2DM was shown [79], probably related to a TFA-induced increase in inflammatory cytokines [13]. Apart from TFA, many bakery products and high-energy prepacked foods contain also relevant amounts of SFA that may be sufficient to increase insulin resistance and risk of diabetes [14, 85]. Epidemiological studies indicate a direct relation of dietary SFA with the incidence of insulin resistance or T2DM [86, 87], whereas replacing SFA by MUFA may improve insulin sensitivity [78] and beneficially influence blood pressure, low-density lipoprotein (LDL) cholesterol, and triacylglycerols [88]. However, recent research also indicates that specific SFA largely differ in function, structure, and metabolic effects, with some SFA having important and specific biological roles [89]. SFA, under conditions of hyperglycemia, can exert damaging effects on B cells, a concept known as glucolipotoxicity [90–93]. Apart from influencing key enzyme activities and transcription factors on an intracellular level [89], a SFA-mediated increase in intramyocellular lipid content and composition may also activate specific serine kinases, finally leading to insulin resistance [94, 95]. Interestingly, FA-induced endoplasmic reticulum stress leading to the activation of sterol-regulatory element-binding protein-1 (SREBP-1) [96] may link both high-fat diet-induced obesity with insulin resistance, and insulin resistance and loss of B-cells on a molecular level. Finally, SFA may influence inflammatory pathways which are related to impaired insulin sensitivity [97]. However, treatment with high-dose acetylic salicylic acid has been shown to reverse lipid-induced insulin resistance in humans, although no changes in selected inflammatory markers were detected [98]. The underlying mechanisms involved in MUFA-induced improvement of insulin sensitivity are subject to further research but may involve effects on cell membrane FA composition [13], with functional effects on membrane fluidity, ion permeability, insulin receptor binding/affinity [13], and upregulation of glucose transporters [14, 99]. Other involved mechanisms might be related to alterations in incretin responses [14, 100, 101] and cytoprotective effects on beta-cell function [14, 102, 103]. In insulin resistant subjects, an isoenergetic MUFA-rich diet prevented central fat redistribution and insulin resistance induced by a carbohydrate-rich diet [104]. Despite these findings, an increased intake of MUFA was not associated with reduced risk of T2DM in prospective cohort studies [105]. PUFA also may reduce insulin resistance based on their anti-inflammatory properties, probably mediated through effects on toll-like receptors (TLRs) [14]. Contrary to the proinflammatory profile of SFA, n-3, PUFA have been shown to inhibit TLR-2 and TLR-4 [106]. Further postulated effects of PUFA on insulin action may include beneficial alterations in membrane fluidity, increased binding affinity of the insulin receptor, and improved glucose transport into cells via glucose transporters [107–109], as well as effects on circulating triglycerides and low-density lipoprotein particles [110]. Finally, effects on the regulation of various genes that are involved in lipid and carbohydrate metabolism have been shown which include peroxisome proliferator-activated receptors, SREBP-1c, hepatic nuclear factors, retinoid X receptors, and liver X receptors [14, 111]. It is, however, important to note that no long-term-randomized trials have been published to date that investigated the effect of dietary fat composition on diabetes risk. Furthermore, many studies investigating potential mechanisms for FA-induced changes in insulin sensitivity have been performed in vitro or in animal models only. There appear to be relevant interspecies differences when comparing metabolic effects of specific FA. As an example, in humans, n-6 PUFA may improve insulin resistance and diabetes risk [13], whereas the reported beneficial effects of n-3 PUFA consumption from marine origin, as shown in rodent models, do not appear to apply [9, 13, 77]. Therefore, further research is needed to investigate the effects of modulation of FA composition on insulin resistance and diabetes risk in humans. Potential Effects of the Genetic Background Genetic differences between subjects exposed to a lipid challenge may play an additional role. We had recently hypothesized that amino acid replacements in liver fatty acid binding protein (L-FABP) might alter its function and thereby affect glucose metabolism in lipid-exposed subjects, as indicated by studies in L-FABP knockout mice [112]. Endogenous glucose production (EGP), gluconeogenesis, and glycogenolysis were measured in healthy carriers of the only common Thr(94)-to-Ala amino acid replacement (Ala/Ala(94)) versus age-, sex-, BMI-, and waist-matched wild-type (Thr/Thr(94)) controls at baseline and after 320 min lipid/heparin-somatostatin-insulin-glucagon clamps. Whole-body glucose disposal was further investigated in a subset, using euglycemic-hyperinsulinemic clamps without and with lipid/heparin infusion. The common Ala/Ala(94)-mutation contributed significantly to reduced glycogenolysis and less severe hyperglycemia in lipid-exposed humans and was further associated with reduced body weight in a large cohort [113]. Whole-body glucose disposal was not different between lipid-exposed L-FABP genotypes [113]. Importantly, investigation of L-FABP phenotypes in the basal overnight-fasted state yielded incomplete information, and a challenge test was essential to detect phenotypical differences in glucose metabolism between L-FABP genotypes [113]. Results indicated that L-FABP may not play a significant role in a normal diet but may contribute to disturbed glucose metabolism in a high-fat diet. However, various other factors unrelated to the L-FABP genotype are difficult to control for in human studies and may have influenced the results. Furthermore, results were obtained under highly experimental conditions using somatostatin infusion and replacement of insulin and glucagon in low fasting doses which may be well different from the situation after the intake of a high fat meal. There could be also ethical implications, particularly when investigating a SNP with potentially adverse effects on health, since even under blinded conditions the likelihood of a participant having the adverse mutation increases to 50% solely by inclusion in the study. Given these difficulties, very few human studies have been performed to date using a similar approach. Future research will be needed to further investigate the influence of the genetic background on diet induced-insulin resistance, with the final aim to design personalised tailored diets that are individually adapted to the needs and metabolic responses of the respective subject. Metabolic Effects of Low-Carbohydrate High-Protein Diets Reduction of carbohydrate content of a diet can be achieved by increasing the content of dietary protein, fat, or a combination of both at the expense of dietary carbohydrates. Since an excess intake of dietary fat is assumed to have unfavorable effects on health, many popular low-carbohydrate diets suggest increasing the content of dietary protein. Apart from better weight loss, these diets appear to have some advantages over other diets that include beneficial effects on body fat distribution, blood pressure, and HDL cholesterol [47, 66]. However, recent studies also indicate that high-protein diets could have detrimental effects on health in the longer term [114, 115]. Wang and colleagues have investigated the metabolite profiles in 2.422 normoglycemic individuals who were followed for 12 years. Of these participants, 201 developed diabetes [116]. Five branched chain and aromatic amino acids (isoleucine, leucine, valine, tyrosine, and phenylalanine) showed significant associations with future diabetes, and results were replicated in an independent, prospective cohort. Authors proposed amino acid profiling as a potential predictor for future diabetes, but a potential causal link between dietary protein intake and future diabetes cannot be excluded. In fact, there is increasing evidence that longer term high-protein intake may have detrimental effects on insulin resistance [68, 117–123], diabetes risk [69], and the risk of developing cardiovascular disease [70]. Therefore, the long-term safety of high-protein diets remains to be investigated [46, 69, 70]. In the Diet, Obesity and Genes (DiOGenes) trial weight regain at 1 year was only marginally lower with a higher protein intake [46]. Insulin sensitivity was not measured in DiOGenes but both the high-protein and the high GI diets significantly increased markers of low-grade inflammation [124], which could result in worsening of insulin resistance. Indeed, a recent study from our group showed significant and clinically relevant worsening of insulin sensitivity with an isoenergetic plant-based high-protein diet, as measured using euglycemic hyperinsulinemic clamps and stable isotope methods [68]. This negative effect on insulin sensitivity was observed despite tailoring the amino acid profile in the high-protein diet to a composition with assumed beneficial metabolic effects [68]. Furthermore, healthy humans that are exposed to amino acid infusions rapidly develop insulin resistance [120], with inhibition of glucose uptake being driven through phosphorylation of downstream factors of the insulin signaling cascade by translation initiation factor serine-kinase-6-1 (S6K1) [120, 121]. In agreement with this, longer term high-protein intake has been shown to result in whole-body insulin resistance [68, 118], associated with upregulation of factors involved in the mammalian target of rapamycin (mTOR)/S6K1 signalling pathway [68], increased stimulation of glucagon and insulin within the endocrine pancreas, high glycogen turnover [118] and stimulation of gluconeogenesis [68, 118]. In the short term, these negative effects of dietary protein on insulin sensitivity may be compensated by high-protein diet-induced weight loss, and, at least in physically active people, relevant increases in lean mass that are also mediated via the mTOR/S6K1 pathway [121]. However, most subjects on weight loss diets are overweight/obese and typically sedentary. Relevant increases in lean mass are unlikely to be achieved under such conditions. In further agreement that high-protein diets may deteriorate glucose metabolism, it was recently shown in a large prospective cohort with 10 years followup that consuming 5% of energy from both animal and total protein at the expense of carbohydrates or fat increases diabetes risk by as much as 30% [69]. This reinforces the theory that high-protein diets can have adverse effects on glucose metabolism. Another recent study showed that low-carbohydrate high-protein diets, used on a regular basis and without consideration of the nature of carbohydrates or the source of proteins, are also associated with increased risk of cardiovascular disease [70], thereby indicating a potential link between high-protein Western diets, T2DM, and cardiovascular risk. The Carnivore Connection Hypothesis [125] proposes that during human evolution a scarcity of dietary carbohydrates together with high intake from animal proteins may have resulted in insulin resistance, thereby providing a survival and reproductive advantage by redirecting glucose from maternal use to fetal metabolism and increased birth weight and survival of the offspring [125]. However, such a diet could be deleterious in a high-carbohydrate environment [123]. In this context, it is interesting that populations who have only recently changed dietary habits from traditional high-protein hunter gatherer to modern high-carbohydrate diets show excessively high prevalence of insulin resistance and T2DM, as compared to European populations that switched to higher carbohydrate intake some 12,000 years ago [125, 126]. Effects of Modulating the Glycemic Index of Carbohydrate-Rich Foods The glycemic index (GI) is a measure of the blood glucose-raising ability of available carbohydrates in foods and defined as the incremental area under the glycemic response curve (AUC) elicited by a portion of food containing 50 g available carbohydrate expressed as a percentage of the AUC elicited by 50 g glucose in the same subject [127]. Related is the concept of the glycemic load (GL), which takes account of the GI of a food and the amount eaten [128]. Low-GI and/or low-GL diets may reduce the risk of metabolic syndrome [129], T2DM [130, 131], cardiovascular disease [132], and chronic inflammation [133], probably by beneficial effects body weight [46, 134–136], insulin sensitivity [137, 138], B-cell function [139, 140], serum cholesterol [141, 142], glycemic control in diabetes [143]. In contrast, carbohydrates that are high in GI lead to rapid onset and pronounced increases of postprandial glucose and insulin concentrations that may compromise fat oxidation, fuel partitioning, and metabolic flexibility [16, 144]. High-GI diets have been linked to insulin resistance in epidemiological observations, whereas low-GI diets improved insulin sensitivity in patients with T2DM [16]. Separating Effects of the GI from Fiber Intake However, separating the effects of single nutrients in complex foods on metabolic outcomes is not straight forward. Many low-GI diets are also rich in cereal fibers which are insoluble in water and have only negligible effects on the GI. However, cereal fiber intake is one of the strongest and most consistent independent factors associated with reduced risk of T2DM in prospective cohort studies [15, 17, 18, 145]. It cannot be excluded that at least some of the effects attributed to a low GI of carbohydrate-rich foods may be related to the cereal fiber content of the diet [15, 146]. Indeed, meta-analyses of large prospective cohort studies consistently show a 20–30% reduction of the risk of developing T2DM in subjects consuming diets high in cereal fiber (relative risk for extreme quintiles (RR); 0.67; 95% CI 0.62–0.72)) [18], whereas results regarding a protective effects of low-GI (and GL) foods are less conclusive [15]. Metabolic Effects of Dietary Fiber Intake Apart from the mainly moderate weight loss that can be achieved with dietary fiber intake from most sources [41], further effects are likely involved in their beneficial action. Key-proposed principles include (i) improvement of total and LDL cholesterol levels that are mainly seen with the intake of viscous, soluble dietary fiber [147], whereas high-density lipoprotein (HDL) cholesterol and triacylglycerols are not relevantly changed [148]; (ii) the commonly proposed concept of fiber induced changes in the gut microbiota and fermentation of nondigestible fiber contents in the colon with increased production of short chain fatty acids (SCFA), with various metabolic effects that are assumed to be beneficial [15, 149–152]. However, and surprisingly, protective effects of fiber intake on the risk of developing insulin resistance and T2DM are consistently shown with a high intake of insoluble and only moderately fermentable cereal fibers and whole grains but not with a higher intake of fruit and vegetables that are generally richer in soluble, fermentable fiber contents [17, 18]. The main sources of cereal fiber in the large prospective cohort studies in the US are cellulose and hemicelluloses from wheat bran [15] that are insoluble in water, nonviscous and only moderately fermentable [15, 153]. Main sources of soluble, viscous, and fermentable fiber are typically fruit and vegetables [15]. The fact that neither intake of fruit (relative risk for extreme quintiles (RR) 0.96; 95% CI 0.88–1.04) nor vegetables (RR 1.04; 95% CI 0.94–1.15) shows any significant associations with reduced risk of developing T2DM in meta-analyses of large prospective cohort studies [18] does not support the hypothesis that viscous properties of dietary fiber influencing the GI or fiber-induced increases of SCFA are key driving factors for reduced diabetes risk, although additional potential beneficial metabolic effects are possible. Fiber-Induced Changes in Colonic Fermentation and the Composition of the Gut Microbiota Recent studies in both experimental models and humans show beneficial effects of food products with prebiotic properties on energy homeostasis, satiety regulation, and body weight gain [154], supporting the hypothesis that the composition of the gut microbiota may contribute to modulate metabolic processes associated with obesity, T2DM, and the metabolic syndrome [154]. However, these studies were almost invariably short term, and the role of such changes in long-term health benefits for the patient remains to be definitively proven [154]. In short-term studies in rodents, fiber-induced changes of the gut microbiota and increased production of SCFA in the colon appear to beneficially influence obesity and insulin resistance [155, 156]. Very few studies have investigated longer-term exposure to fermentable fiber in humans and animal models [152, 157, 158]. Track and colleagues investigated male Wistar rats over 67 weeks and found that short-term feeding with guar gum as compared with cellulose or bran had favorable effects on body weight and makers of carbohydrate tolerance. However, in the long term, these effects were absent, with a tendency to increased body weight and significantly higher pancreatic insulin and glucagon concentrations in the guar fed rats [158]. Similar results were observed in a long-term experiment from our group, comparing effects of adding different sorts of fiber to high fat diet fed C57BL/6J mice. Animals that were fed otherwise identical diets differing in soluble/fermentable (guar gum) versus insoluble/nonfermentable fiber (purified cereal fiber extract that was not fermentable in vitro) showed short-term beneficial effects of soluble fiber intake, but again these were completely abolished in the long term [157]: guar fed mice exhibited higher energy extraction of the diet with SCFA cumulatively contributing to total energy intake, resulting in a significantly more obese, insulin resistant phenotype when compared to mice receiving nonfermentable cereal fiber [157]. Such a phenomenon could be also relevant in humans, as indicated by early studies showing that fiber-induced increases of SCFA may contribute as much as 10% to total energy intake [159]. Interestingly, colonization of germ-free gnotobiotic mice with a prominent saccharolytic member of the normal human gut microbiota together with dominant human methane-producing germs results in markedly improved colonic fermentation and is associated with an obese phenotype in the host [160]. However, it is not clear whether these results apply in other species. In humans, both the magnitude and the importance of fiber-induced changes in the gut microbiota and colonic fermentation remain largely unknown [155]. No long-term human studies exist that have investigated the effects of otherwise identical diets differing in soluble, fermentable versus insoluble cereal fiber contents only, and insight about potential beneficial effects of fiber-derived production of SCFA on insulin sensitivity is almost exclusively derived from short-term studies [161–164]. The same is true for studies that have focused on effects of prebiotics or carbohydrates with prebiotic properties in overweight persons or patients with T2DM, typically lasting between 4 and 12 weeks [165–172]. Only one long-term controlled study in 14 humans per group investigated the effects of an increase of the intake of moderately fermentable wheat fiber by 20 g/day on SCFA, glucagon, like peptide 1 (GLP-1) levels, and markers of insulin sensitivity over a 1-year period [152]. Authors showed that the wheat bran-rich diet increased circulating levels of GLP-1 at 12 month, but not earlier in the intervention, whereas plasma acetate and butyrate showed a transient increase at 9 month only [152]. Therefore, a convincing relation between fiber-induced changes in SCFA and circulating GLP-1 levels was not provided. Furthermore, it has been shown previously that propionate and butyrate are quantitatively taken up by the liver and can be almost undetectable in peripheral blood [173], whereas acetate might be not specifically attributed to SCFA production of gut microbiota. Portal vein blood sampling would yield more feasible results, but is too invasive for this purpose. No changes in markers of insulin sensitivity (homeostasis model assessment for insulin resistance (HOMA-IR)) were observed in the study of Freeland [152], but this does not exclude potential changes since other studies have reported fiber-induced improvement of insulin sensitivity using euglycemic hyperinsulinemic clamps as the gold standard method which would have been missed by using HOMA-IR only [68, 161]. Further evidence supporting that at least in humans fiber-induced increases in SCFA may not exclusively explain changes in insulin sensitivity comes from a series of recent studies. In a short-term-randomized-controlled cross-over study from our laboratory, 14 healthy participants consumed nonfermentable-purified cereal fiber extracts from wheat, or moderately fermentable extracts from oat hulls, or highly fermentable insoluble resistant starch, or low-fiber control. Both the consumption of the cereal fiber extracts and of resistant starch showed comparable and significant improvement of postprandial glucose handling in a second meal test the next day, although products largely differed in their fermentability as indicated by hydrogen breath tests [174]. These findings are supported by further studies showing similar second meal effects after the intake of various fiber-related substances largely differing in their rate of colonic fermentation [163, 175–179]. Notably, most of these studies were of too short duration to upregulate GLP-1 mRNA expression and showed not any effects on GLP-1 levels. Furthermore, in a 4-week study, Robertson et al. showed that consumption of highly fermentable resistant starch significantly improved whole-body insulin sensitivity using euglycemic hyperinsulinemic clamps, in the absence of any effect on circulating GLP-1 [162]. Despite the lack of convincing effects on colonic fermentation, insoluble cereal fiber intake, under isoenergetic conditions, increases whole-body insulin sensitivity in both short-term and more prolonged studies, as measured using euglycaemic-hyperinsulinaemic clamps [15, 68, 180]. These effects appear to be dose-dependent [15] but independent of colonic fermentation, changes in dominant groups of the gut microbiota, or circulating GLP-1 [15, 68, 153]. We have recently proposed a novel concept that could contribute to explaining improved insulin sensitivity with cereal fiber intake, showing that cereal fiber may hinder the digestion and/or absorption of dietary protein in the upper gut, thereby preventing amino-acid-induced activation of the mammalian target of rapamycin (mTOR)/translation initiation factor serine-kinase-6-1 (S6K1) signalling pathway that is known to drive insulin resistance [68, 120, 121]. Cereal diet-induced effects on whole-body insulin sensitivity were not matched by changes in markers of colonic fermentation and/or the composition of the gut microbiota, neither in the full model nor in additionally performed uncorrected subgroup analyses, and there was also no tendency to more pronounced effects after 18 versus 6 weeks of dietary intervention [153]. Insoluble cereal fibers generally show no major direct effects on the modulation of blood lipids, but may indirectly influence these parameters at the long term via improvement of whole body insulin sensitivity [15, 68, 161–163, 174, 175, 177, 178, 181]. Further potential effects of cereal fiber intake may include the modulation of gut hormones, adipokines, bile acid binding, and metabolite profiles which deserve further investigation. Conclusions Weight loss with the reduction of abdominal fat mass almost invariably reverses insulin resistance as a consequence of chronic excessive energy intake in relation to physical activity levels. Therefore, any safe and balanced life-style measures that lead to weight loss and can be sustained in the long term have the potential to improve insulin resistance and glycemic control. However, particularly in patients with T2DM, long-term-sustained weight loss appears to be difficult to achieve. In this situation, isoenergetic changes of the macronutrient composition and the quality of ingested foods may exert important additional effects on insulin sensitivity. Nutritional measures that could be useful in this context include a Mediterranean-like dietary pattern, but avoiding excess intake of dietary fat; substituting SFA and TFA by MUFA and n-6 PUFA; increasing cereal fiber intake, particularly when choosing a high-protein dietary strategy. Weight loss, the macronutrient composition of the respective diet, aerobic exercise, and resistance training all appear to improve insulin resistance, by distinct mechanisms. Therefore, a combination of these interventions tailored to the requirements of each subject should be one of the cornerstones of management [8, 19, 182]. For the planning of an optimal diet, further aspects are likely to be important which may include the consideration of gender differences [183], varying effects of specific diets depending on the ethnic background [184], genetic variation including potential differences in response to a diet in carriers of certain single-nucleotide polymorphisms, differences between individuals in the metabolite profiles, comorbidities, the intake and interactions of certain drugs, and the exposure to other environmental factors than the diet. Further, elucidating these aspects may ultimately lead to personalized dietary strategies that are tailored to the specific needs of the individual. Conflict of Interests The author assures that there was no conflict of interests. References - D. Burkitt, “Food fiber and disease prevention,” Comprehensive Therapy, vol. View at Scopus - D. P. Burkitt, “Fibre depleted carbohydrates and disease,” Community Health, vol. View at Scopus - H. Trowell, “Ischemic heart disease and dietary fiber,” American Journal of Clinical Nutrition, vol. View at Scopus - H. Trowell, “Fiber: a natural hypocholesteremic agent,” American Journal of Clinical Nutrition, vol. View at Scopus - A. R. Walker, “The effect of recent changes of food habits on bowel motility,” South African Medical Journal, vol. - B. Neal, “White rice and risk of type 2 diabetes,” British Medical Journal, vol. View at Publisher · View at Google Scholar - K. M. V. Narayan, J. P. Boyle, T. J. Thompson, S. W. Sorensen, and D. F. Williamson, “Lifetime risk for diabetes mellitus in the united states,” Journal of the American Medical Association, vol. View at Publisher · View at Google Scholar · View at Scopus - S. R. Colberg, R. J. Sigal, B. Fernhall et al., “Exercise and type 2 diabetes: the american college of sports medicine and the american diabetes association: joint position statement,” Diabetes Care, vol. View at Publisher · View at Google Scholar · View at Scopus - K. McAuley and J. Mann, “Thematic review series: patient-oriented research. nutritional determinants of insulin resistance,” Journal of Lipid Research, vol. View at Publisher · View at Google Scholar · View at Scopus - G. Vazquez, S. Duval, D. R. Jacobs, and K. Silventoinen, “Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis,” Epidemiologic Reviews, vol. View at Publisher · View at Google Scholar · View at Scopus - K. C. Sung, W. S. Jeong, S. H. Wild, and C. D. Byrne, “Combined influence of insulin resistance, overweight/obesity, and Fatty liver as risk factors for type 2 diabetes,” Diabetes Care, vol. - C. M. Kastorini, H. J. Milionis, K. Esposito, D. Giugliano, J. A. Goudevenos, and D. B. Panagiotakos, “The effect of mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals,” Journal of the American College of Cardiology, vol. View at Publisher · View at Google Scholar · View at Scopus - U. Risérus, W. C. Willett, and F. B. Hu, “Dietary fats and prevention of type 2 diabetes,” Progress in Lipid Research, vol. View at Publisher · View at Google Scholar · View at Scopus - T. Thomas and A. F. Pfeiffer, “Foods for the prevention of diabetes: how do they work?” Diabetes Metabolism Research Reviews, vol. View at Publisher · View at Google Scholar - M. O. Weickert and A. F. H. Pfeiffer, “Metabolic effects of dietary fiber consumption and prevention of diabetes,” Journal of Nutrition, vol. View at Scopus - J. Brand-Miller, J. McMillan-Price, K. Steinbeck, and I. Caterson, “Dietary glycemic index: health implications,” Journal of the American College of Nutrition, vol. 28, supplement 4, pp. 446S–449S, 2009. View at Scopus - J. S. L. De Munter, F. B. Hu, D. Spiegelman, M. Franz, and R. M. Van Dam, “Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review,” PLoS Medicine, vol. View at Publisher · View at Google Scholar · View at Scopus - M. B. Schulze, M. Schulz, C. Heidemann, A. Schienkiewitz, K. Hoffmann, and H. Boeing, “Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis,” Archives of Internal Medicine, vol. View at Publisher · View at Google Scholar · View at Scopus - ADA, “Standards of medical care in diabetes,” Diabetes Care, vol. 34, supplement 1, pp. View at Publisher · View at Google Scholar - M. C. Gomez-Cabrera, M. Ristow, and J. Vina, “Antioxidant supplements in exercise: worse than useless?” American Journal Physiology Endocrinology and Metabolism, vol. View at Publisher · View at Google Scholar - F. L. Brancati, N. Y. Wang, L. A. Mead, K. Y. Liang, and M. J. Klag, “Body weight patterns from 20 to 49 years of age and subsequent risk for diabetes mellitus: the Johns Hopkins precursors study,” Archives of Internal Medicine, vol. View at Publisher · View at Google Scholar · View at Scopus - L. Newburgh, “Control of the hyperglycemia of obese "diabetics" by weight reduction,” Annals of Internal Medicine, vol. - D. E. Kelley, R. Wing, C. Buonocore, J. Sturis, K. Polonsky, and M. Fitzsimmons, “Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. View at Publisher · View at Google Scholar · View at Scopus - R. R. Wing, R. Koeske, L. H. Epstein, M. P. Nowalk, W. Gooding, and D. Becker, “Long-term effects of modest weight loss in type II diabetic patients,” Archives of Internal Medicine, vol. View at Scopus - J. B. Redmon, K. P. Reck, S. K. Raatz et al., “Two-year outcome of a combination of weight loss therapies for type 2 diabetes,” Diabetes Care, vol. View at Publisher · View at Google Scholar · View at Scopus - C. A. Maggio and F. X. Pi-Sunyer, “The prevention and treatment of obesity: application to type 2 diabetes,” Diabetes Care, vol. View at Scopus - F. X. Pi-Sunyer, “Weight loss in type 2 diabetic patients,” Diabetes Care, vol. View at Publisher · View at Google Scholar · View at Scopus - G. A. Bray, “Effect of caloric restriction on energy expenditure in obese patients,” The Lancet, vol. View at Scopus - S. Heshka, Y. Mei-Uih, J. Wang, P. Burt, and F. X. Pi-Sunyer, “Weight loss and change in resting metabolic rate,” American Journal of Clinical Nutrition, vol. View at Scopus - C. Bogardus, M. R. Taskinen, J. Zawadzki, S. Lillioja, D. Mott, and B. V. Howard, “Increased resting metabolic rates in obese subjects with non-insulin-dependent diabetes mellitus and the effect of sulfonylurea therapy,” Diabetes, vol. View at Scopus - K. S. Nair, D. Halliday, and J. S. Garrow, “Increased energy expenditure in poorly controlled type 1 (insulin-dependent) diabetic patients,” Diabetologia, vol. View at Scopus - R. M. Milne, J. I. Mann, A. W. Chisholm, and S. M. Williams, “Long-term comparison of three dietary prescriptions in the treatment of NIDDM,” Diabetes Care, vol. View at Scopus - K. M. Beavers, M. F. Lyles, C. C. Davis, X. Wang, D. P. Beavers, and B. J. Nicklas, “Is lost lean mass from intentional weight loss recovered during weight regain in postmenopausal women?” American Journal of Clinical Nutrition, vol. - N. G. Boulé, E. Haddad, G. P. Kenny, G. A. Wells, and R. J. Sigal, “Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials,” Journal of the American Medical Association, vol. View at Scopus - V. S. Malik and F. B. Hu, “Popular weight-loss diets: from evidence to practice,” Nature Clinical Practice Cardiovascular Medicine, vol. - A. Astrup, G. K. Grunwald, E. L. Melanson, W. H. Saris, and J. O. Hill, “The role of low-fat diets in body weight control: a meta-analysis of ad libitum dietary intervention studies,” International Journal Obesity Related Metabolic Disorders, vol. - S. Pirozzo, C. Summerbell, C. Cameron, and P. Glasziou, “Advice on low-fat diets for obesity,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD003640, 2002. View at Scopus - A. D. McClain, J. J. Otten, E. B. Hekler, and C. D. Gardner, “Adherence to a low-fat versus low-carbohydrate diet differs by insulin resistance status,” Diabetes Obesity & Metabolism. In press. View at Publisher · View at Google Scholar - A. J. Nordmann, A. Nordmann, M. Briel et al., “Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials,” Archives of Internal Medicine, vol. View at Publisher · View at Google Scholar · View at Scopus - D. S. Ludwig, M. A. Pereira, C. H. Kroenke et al., “Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults,” Journal of the American Medical Association, vol. View at Publisher · View at Google Scholar · View at Scopus - N. C. Howarth, E. Saltzman, and S. B. Roberts, “Dietary fiber and weight regulation,” Nutrition Reviews, vol. View at Scopus - M. H. Pittler and E. Ernst, “Guar gum for body weight reduction: meta-analysis of randomized trials,” American Journal of Medicine, vol. View at Publisher · View at Google Scholar · View at Scopus - P. Koh-Banerjee and E. B. Rimm, “Whole grain consumption and weight gain: a review of the epidemiological evidence, potential mechanisms and opportunities for future research,” Proceedings of the Nutrition Society, vol. View at Publisher · View at Google Scholar · View at Scopus - D. E. Thomas, E. J. Elliott, and L. Baur, “Low glycaemic index or low glycaemic load diets for overweight and obesity,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD005105, 2007. View at Scopus - B. Sloth, I. Krog-Mikkelsen, A. Flint et al., “No difference in body weight decrease between a low-glycemic-index and a high-glycemic-index diet but reduced LDL cholesterol after 10-wk ad libitum intake of the low-glycemic-index diet,” American Journal of Clinical Nutrition, vol. View at Scopus - T. M. Larsen, S. M. Dalskov, M. Van Baak et al., “Diets with high or low protein content and glycemic index for weight-loss maintenance,” New England Journal of Medicine, vol. View at Publisher · View at Google Scholar · View at Scopus - M. Hession, C. Rolland, U. Kulkarni, A. Wise, and J. Broom, “Systematic review of randomized controlled trials of low-carbohydrate vs. low-fat/low-calorie diets in the management of obesity and its comorbidities,” Obesity Reviews, vol. View at Publisher · View at Google Scholar · View at Scopus - D. S. Weigle, P. A. Breen, C. C. Matthys et al., “A high-protein diet induces sustained reductions in appetite, ad libitum caloric intake, and body weight despite compensatory changes in diurnal plasma leptin and ghrelin concentrations,” American Journal of Clinical Nutrition, vol. View at Scopus - G. D. Foster, H. R. Wyatt, J. O. Hill et al., “A randomized trial of a low-carbohydrate diet for obesity,” New England Journal of Medicine, vol. View at Publisher · View at Google Scholar · View at Scopus - F. F. Samaha, N. Iqbal, P. Seshadri et al., “A low-carbohydrate as compared with a low-fat diet in severe obesity,” New England Journal of Medicine, vol. View at Publisher · View at Google Scholar · View at Scopus - P. Shah and W. L. Isley, “Ketoacidosis during a low-carbohydrate diet,” New England Journal of Medicine, vol. View at Publisher · View at Google Scholar · View at Scopus - J. O. Hill, J. C. Peters, G. W. Reed, D. G. Schlundt, T. Sharp, and H. L. Greene, “Nutrient balance in humans: effects of diet composition,” American Journal of Clinical Nutrition, vol. View at Scopus - J. D. Latner and M. Schwartz, “The effects of a high-carbohydrate, high-protein or balanced lunch upon later food intake and hunger ratings,” Appetite, vol. View at Publisher · View at Google Scholar · View at Scopus - S. D. Poppitt, D. McCorMacK, and R. Buffenstein, “Short-term effects of macronutrient preloads on appetite and energy intake in lean women,” Physiology and Behavior, vol. View at Publisher · View at Google Scholar · View at Scopus - B. J. Rolls, M. Hetherington, and V. J. Burley, “The specificity of satiety: the influence of foods of different macronutrient content on the development of satiety,” Physiology and Behavior, vol. View at Scopus - R. J. Stubbs, M. C. W. Van Wyk, A. M. Johnstone, and C. G. Harbron, “Breakfasts high in protein, fat or carbohydrate: Effect on within-day appetite and energy balance,” European Journal of Clinical Nutrition, vol. View at Scopus - A. Due, S. Toubro, A. R. Skov, and A. Astrup, “Effect of normal-fat diets, either medium or high in protein, on body weight in overweight subjects: a randomised 1-year trial,” International Journal of Obesity, vol. View at Publisher · View at Google Scholar · View at Scopus - A. R. Skov, S. Toubro, B. Rønn, L. Holm, and A. Astrup, “Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity,” International Journal of Obesity, vol. View at Scopus - S. K. Arora and S. I. McFarlane, “The case for low carbohydrate diets in diabetes management,” Nutrition and Metabolism, vol. View at Publisher · View at Google Scholar · View at Scopus - R. C. Atkins, D. Ornish, and T. Wadden, “Low-carb, low-fat diet gurus face off. interview by Joan Stephenson,” Journal of the American Medical Association, vol. View at Scopus - C. S. Johnston, S. L. Tjonn, P. D. Swan, A. White, H. Hutchins, and B. Sears, “Ketogenic low-carbohydrate diets have no metabolic advantage over nonketogenic low-carbohydrate diets,” American Journal of Clinical Nutrition, vol. View at Scopus - A. K. Gosby, A. D. Conigrave, N. S. Lau, et al., “Testing protein leverage in lean humans: a randomised controlled experimental study,” PLoS One, vol. View at Publisher · View at Google Scholar - P. B. Mikkelsen, S. Toubro, and A. Astrup, “Effect of fat-reduced diets on 24-h energy expenditure: comparisons between animal protein, vegetable protein, and carbohydrate,” American Journal of Clinical Nutrition, vol. View at Scopus - R. Swaminathan, R. F. G. J. King, J. Holmfield, and R. A. Siwek, “Thermic effect of feeding carbohydrate, fat, protein and mixed meal in lean and obese subjects,” American Journal of Clinical Nutrition, vol. View at Scopus - K. R. Westerterp, S. A. J. Wilson, and V. Rolland, “Diet induced thermogenesis measured over 24 h in a respiration chamber: effect of diet composition,” International Journal of Obesity, vol. View at Scopus - D. K. Layman, E. M. Evans, D. Erickson et al., “A moderate-protein diet produces sustained weight loss and long-term changes in body composition and blood lipids in obese adults,” Journal of Nutrition, vol. View at Publisher · View at Google Scholar · View at Scopus - M. L. Dansinger, J. A. Gleason, J. L. Griffith, H. P. Selker, and E. J. Schaefer, “Comparison of the atkins, ornish, weight watchers, and zone Diets for weight loss and heart disease risk reduction: a randomized trial,” Journal of the American Medical Association, vol. View at Publisher · View at Google Scholar · View at Scopus - M. O. Weickert, M. Roden, F. Isken et al., “Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans,” American Journal of Clinical Nutrition, vol. View at Publisher · View at Google Scholar · View at Scopus - I. Sluijs, J. W. J. Beulens, D. L. Van Der A, A. M. W. Spijkerman, D. E. Grobbee, and Y. T. Van Der Schouw, “Dietary intake of total, animal, and vegetable protein and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-NL study,” Diabetes Care, vol. View at Publisher · View at Google Scholar · View at Scopus - P. Lagiou, S. Sandin, E. Weiderpass et al., “Low carbohydrate-high protein diet and mortality in a cohort of swedish women,” Journal of Internal Medicine, vol. View at Publisher · View at Google Scholar · View at Scopus - B. B. Alford, A. C. Blankenship, and R. D. Hagen, “The effects of variations in carbohydrate, protein, and fat content of the diet upon weight loss, blood values, and nutrient intake of adult obese women,” Journal of the American Dietetic Association, vol. View at Scopus - A. Golay, A. F. Allaz, Y. Morel, N. De Tonnac, S. Tankova, and G. Reaven, “Similar weight loss with low- or high-carbohydrate diets,” American Journal of Clinical Nutrition, vol. View at Scopus - A. Golay, A. F. Allaz, J. Ybarra et al., “Similar weight loss with low-energy food combining or balanced diets,” International Journal of Obesity and Related Metabolic Disorders, vol. View at Scopus - F. M. Sacks, G. A. Bray, V. J. Carey et al., “The new England journal of medicine: comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates,” New England Journal of Medicine, vol. View at Publisher · View at Google Scholar · View at Scopus - K. Nagy, J. Levy, and G. Grunberger, “High-fat feeding induces tissue-specific alteration in proportion of activated insulin receptors in rats,” Acta Endocrinologica, vol. View at Scopus - X. R. Pan, G. W. Li, Y. H. Hu et al., “Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and diabetes study,” Diabetes Care, vol. View at Scopus - L. H. Storlien, A. B. Jenkins, D. J. Chisholm, W. S. Pascoe, S. Khouri, and E. W. Kraegen, “Influence of dietary fat composition on development of insulin resistance in rats. relationship to muscle triglyceride and w-3 fatty acids in muscle phospholipid,” Diabetes, vol. View at Scopus - B. Vessby, M. Uusitupa, K. Hermansen et al., “Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU study,” Diabetologia, vol. View at Publisher · View at Google Scholar · View at Scopus - J. Salmerón, F. B. Hu, J. E. Manson et al., “Dietary fat intake and risk of type 2 diabetes in women,” American Journal of Clinical Nutrition, vol. View at Scopus - D. Mozaffarian, “Trans fatty acids—effects on systemic inflammation and endothelial function,” Atherosclerosis Supplements, vol. View at Publisher · View at Google Scholar · View at Scopus - K. V. Axen, A. Dikeakos, and A. Sclafani, “High dietary fat promotes syndrome X in nonobese rats,” Journal of Nutrition, vol. View at Scopus - A. Ibrahim, S. Natarajan, and Ghafoorunissa, “Dietary trans-fatty acids alter adipocyte plasma membrane fatty acid composition and insulin sensitivity in rats,” Metabolism, vol. View at Publisher · View at Google Scholar · View at Scopus - S. Natarajan, A. Ibrahim, and Ghafoorunissa, “Dietary trans fatty acids alter diaphragm phospholipid fatty acid composition, triacylglycerol content glucose transport in rats,” British Journal of Nutrition, vol. View at Publisher · View at Google Scholar · View at Scopus - D. Mozaffarian, A. Aro, and W. C. Willett, “Health effects of trans-fatty acids: experimental and observational evidence,” European Journal of Clinical Nutrition, vol. 63, supplement 2, pp. View at Publisher · View at Google Scholar · View at Scopus - G. Cascio, G. Schiera, and I. Di Liegro, “Dietary fatty acids in metabolic syndrome, diabetes and cardiovascular diseases,” Current Diabetes Reviews, vol. - D. E. Laaksonen, T. A. Lakka, H. M. Lakka et al., “Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men,” Diabetic Medicine, vol. View at Publisher · View at Google Scholar · View at Scopus - B. Vessby, A. Aro, E. Skarfors, L. Berglund, I. Salminen, and H. Lithell, “The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters,” Diabetes, vol. View at Scopus - G. Riccardi, R. Giacco, and A. A. Rivellese, “Dietary fat, insulin sensitivity and the metabolic syndrome,” Clinical Nutrition, vol. View at Publisher · View at Google Scholar · View at Scopus - V. Rioux and P. Legrand, “Saturated fatty acids: simple molecular structures with complex cellular functions,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. View at Publisher · View at Google Scholar · View at Scopus - V. Poitout and R. P. Robertson, “Glucolipotoxicity: fuel excess and B-cell dysfunction,” Endocrine Reviews, vol. View at Publisher · View at Google Scholar · View at Scopus - S. Gremlich, C. Bonny, G. Waeber, and B. Thorens, “Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels,” Journal of Biological Chemistry, vol. View at Publisher · View at Google Scholar · View at Scopus - B. Ritz-Laser, P. Meda, I. Constant et al., “Glucose-induced preproinsulin gene expression is inhibited by the free fatty acid palmitate,” Endocrinology, vol. View at Scopus - S. Jacqueminet, I. Briaud, C. Rouault, G. Reach, and V. Poitout, “Inhibition of insulin gene expression by long-term exposure of pancreatic B cells to palmitate is dependent on the presence of a stimulatory glucose concentration,” Metabolism: Clinical and Experimental, vol. View at Scopus - M. Roden, “Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes,” International Journal of Obesity, vol. 29, supplement 2, pp. View at Publisher · View at Google Scholar · View at Scopus - M. Yuan, N. Konstantopoulos, J. Lee et al., “Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IkkB,” Science, vol. View at Publisher · View at Google Scholar · View at Scopus - H. Wang, G. Kouri, and C. B. Wollheim, “ER stress and SREBP-1 activation are implicated in B-cell glucolipotoxicity,” Journal of Cell Science, vol. View at Publisher · View at Google Scholar · View at Scopus - K. Mayer, S. Meyer, M. Reinholz-Muhly et al., “Short-time infusion of fish oil-based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans,” Journal of Immunology, vol. View at Scopus - M. Möhlig, M. Freudenberg, T. Bobbert et al., “Acetylsalicylic acid improves lipid-induced insulin resistance in healthy men,” Journal of Clinical Endocrinology and Metabolism, vol. View at Publisher · View at Google Scholar · View at Scopus - N. Dimopoulos, M. Watson, K. Sakamoto, and H. S. Hundal, “Differential effects of palmitate and palmitoleate on insulin action and glucose utilization in rat L6 skeletal muscle cells,” Biochemical Journal, vol. View at Publisher · View at Google Scholar · View at Scopus - F. Soriguer, F. Moreno, G. Rojo-Martínez et al., “Monounsaturated n-9 fatty acids and adipocyte lipolysis in rats,” British Journal of Nutrition, vol. View at Publisher · View at Google Scholar · View at Scopus - C. Thomsen, H. Storm, J. J. Holst, and K. Hermansen, “Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes,” American Journal of Clinical Nutrition, vol. View at Scopus - N. G. Morgan, S. Dhayal, E. Diakogiannaki, and H. J. Welters, “The cytoprotective actions of long-chain mono-unsaturated fatty acids in pancreatic B-cells,” Biochemical Society Transactions, vol. View at Publisher · View at Google Scholar · View at Scopus - G. Rojo-Martínez, I. Esteva, M. S. Ruiz de Adana et al., “Dietary fatty acids and insulin secretion: a population-based study,” European Journal of Clinical Nutrition, vol. View at Publisher · View at Google Scholar · View at Scopus - J. A. Paniagua González, A. Gallego De La Sacristana, I. Romero et al., “Monounsaturated fat-rich diet prevents central body fat distribution and decreases postprandial adiponectin expression induced by a carbohydrate-rich diet in insulin-resistant subjects,” Diabetes Care, vol. View at Publisher · View at Google Scholar · View at Scopus - J. Salas-Salvadó, M. Á. Martinez-Gonzalez, M. Bulló, and E. Ros, “The role of diet in the prevention of type 2 diabetes,” Nutrition, Metabolism & Cardiovascular Diseases, vol. 21, supplement 2, pp. - J. Y. Lee, L. Zhao, H. S. Youn et al., “Saturated fatty acid activates but polyunsaturated fatty acid Inhibits toll-like receptor 2 dimerized with toll-like receptor 6 or 1,” Journal of Biological Chemistry, vol. View at Publisher · View at Google Scholar · View at Scopus - J. C. Lovejoy, “The influence of dietary fat on insulin resistance,” Current Diabetes Reports, vol. View at Scopus - T. Kamada, T. Yamashita, Y. Baba, et al., “Dietary sardine oil increases erythrocyte membrane fluidity in diabetic patients,” Diabetes, vol. View at Scopus - B. Vessby, “Dietary fat and insulin action in humans,” British Journal of Nutrition, vol. 83, supplement 1, pp. View at Scopus - D. Fedor and D. S. Kelley, “Prevention of insulin resistance by n-3 polyunsaturated fatty acids,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. View at Publisher · View at Google Scholar · View at Scopus - D. B. Jump, D. Botolin, Y. Wang, J. Xu, B. Christian, and O. Demeure, “Fatty acid regulation of hepatic gene transcription,” Journal of Nutrition, vol. View at Scopus - E. P. Newberry, Y. Xie, S. M. Kennedy, J. Luo, and N. O. Davidson, “Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice,” Hepatology, vol. View at Publisher · View at Google Scholar · View at Scopus - M. O. Weickert, C. V. Loeffelholz, M. Roden et al., “A Thr94Ala mutation in human liver fatty acid-binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucose levels in lipid-exposed subjects,” American Journal of Physiology Endocrinology and Metabolism, vol. View at Publisher · View at Google Scholar · View at Scopus - C. B. Newgard, “Interplay between lipids and branched-chain amino acids in development of insulin resistance,” Cell Metabolism, vol. - C. B. Newgard, J. An, J. R. Bain et al., “A Branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance,” Cell Metabolism, vol. View at Publisher · View at Google Scholar · View at Scopus - T. J. Wang, M. G. Larson, R. S. Vasan et al., “Metabolite profiles and the risk of developing diabetes,” Nature Medicine, vol. View at Publisher · View at Google Scholar · View at Scopus - M. Krebs, M. Krssak, E. Bernroider et al., “Mechanism of amino acid-induced skeletal muscle insulin resistance in humans,” Diabetes, vol. View at Scopus - T. Linn, B. Santosa, D. Grönemeyer et al., “Effect of long-term dietary protein intake on glucose metabolism in humans,” Diabetologia, vol. View at Publisher · View at Google Scholar · View at Scopus - F. Tremblay, S. Brûlé, H. U. Sung et al., “Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance,” Proceedings of the National Academy of Sciences of the United States of America, vol. View at Publisher · View at Google Scholar · View at Scopus - F. Tremblay, M. Krebs, L. Dombrowski et al., “Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability,” Diabetes, vol. View at Publisher · View at Google Scholar · View at Scopus - S. H. Um, D. D'Alessio, and G. Thomas, “Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1,” Cell Metabolism, vol. View at Publisher · View at Google Scholar · View at Scopus - S. H. Um, F. Frigerio, M. Watanabe et al., “Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity,” Nature, vol. View at Publisher · View at Google Scholar · View at Scopus - M. O. Weickert, “What dietary modification best improves insulin sensitivity and why?” Clinical Endocrinology, vol. View at Publisher · View at Google Scholar - O. Gögebakan, A. Kohl, and M. A. Osterhoff, “Effects of weight loss and long-term weight maintenance with diets varying in protein and glycemic index on cardiovascular risk factors: the diet, obesity, and genes (DiOGenes) study: a randomized, controlled trial,” Circulation, vol. - J. C. Brand-Miller, H. J. Griffin, and S. Colagiuri, “The carnivore connection hypothesis: revisited,” Journal of Obesity, vol. View at Publisher · View at Google Scholar - L. Chen, D. J. Magliano, and P. Z. Zimmet, “The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives,” Nature Reviews Endocrinology, vol. View at Publisher · View at Google Scholar - T. M. S. Wolever, J. C. Brand-Miller, J. Abernethy et al., “Measuring the glycemic index of foods: interlaboratory study,” American Journal of Clinical Nutrition, vol. View at Scopus - B. J. Venn and T. J. Green, “Glycemic index and glycemic load: measurement issues and their effect on diet-disease relationships,” European Journal of Clinical Nutrition, vol. 61, supplement 1, pp. View at Publisher · View at Google Scholar · View at Scopus - N. M. McKeown, J. B. Meigs, S. Liu, E. Saltzman, P. W. F. Wilson, and P. F. Jacques, “Carbohydrate Nutrition, Insulin Resistance, and the prevalence of the metabolic syndrome in the framingham offspring cohort,” Diabetes Care, vol. View at Publisher · View at Google Scholar · View at Scopus - J. Salmerón, A. Ascherio, E. B. Rimm et al., “Dietary fiber, glycemic load, and risk of NIDDM in men,” Diabetes Care, vol. View at Scopus - J. Salmerón, J. E. Manson, M. J. Stampfer, G. A. Colditz, A. L. Wing, and W. C. Willett, “Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women,” Journal of the American Medical Association, vol. View at Scopus - S. Liu, W. C. Willett, M. J. Stampfer et al., “A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women,” American Journal of Clinical Nutrition, vol. View at Scopus - S. Liu, J. E. Manson, J. E. Buring, M. J. Stampfer, W. C. Willett, and P. M. Ridker, “Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women,” American Journal of Clinical Nutrition, vol. View at Scopus - C. B. Ebbeling, M. M. Leidig, K. B. Sinclair, J. P. Hangen, and D. S. Ludwig, “A reduced-glycemic load diet in the treatment of adolescent obesity,” Archives of Pediatrics and Adolescent Medicine, vol. View at Publisher · View at Google Scholar · View at Scopus - J. McMillan-Price, P. Petocz, F. Atkinson et al., “Comparison of 4 diets of varying glycemic load on weight loss and cardiovascular risk reduction in overweight and obese young adults: a randomized controlled trial,” Archives of Internal Medicine, vol. View at Publisher · View at Google Scholar · View at Scopus - M. Slabber, H. C. Barnard, J. M. Kuyl, A. Dannhauser, and R. Schall, “Effects of a low-insulin-response, energy-restricted diet on weight loss and plasma insulin concentrations in hyperinsulinemic obese females,” American Journal of Clinical Nutrition, vol. View at Scopus - G. Frost, A. Leeds, G. Trew, R. Margara, and A. Dornhorst, “Insulin sensitivity in women at risk of coronary heart disease and the effect of a low glycemic diet,” Metabolism, vol. View at Publisher · View at Google Scholar · View at Scopus - S. W. Rizkalla, L. Taghrid, M. Laromiguiere et al., “Improved plasma glucose control, whole-body glucose utilization, and lipid profile on a low-glycemic index diet in type 2 diabetic men: a randomized controlled trial,” Diabetes Care, vol. View at Publisher · View at Google Scholar · View at Scopus - K. S. Juntunen, D. E. Laaksonen, K. S. Poutanen, L. K. Niskanen, and H. M. Mykkänen, “High-fiber rye bread and insulin secretion and sensitivity in healthy postmenopausal women,” American Journal of Clinical Nutrition, vol. View at Scopus - T. M. S. Wolever and C. Mehling, “High-carbohydrate-low-glycaemic index dietary advice improves glucose disposition index in subjects with impaired glucose tolerance,” British Journal of Nutrition, vol. View at Scopus - G. Frost, A. A. Leeds, C. J. Doré, S. Madeiros, S. Brading, and A. Dornhorst, “Glycaemic index as a determinant of serum HDL-cholesterol concentration,” The Lancet, vol. View at Publisher · View at Google Scholar · View at Scopus - S. Kelly, G. Frost, V. Whittaker, and C. Summerbell, “Low glycaemic index diets for coronary heart disease,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD004467, 2004. View at Scopus - J. Brand-Miller, S. Hayne, P. Petocz, and S. Colagiuri, “Low-glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled trials,” Diabetes Care, vol. View at Publisher · View at Google Scholar · View at Scopus - F. Isken, S. Klaus, K. J. Petzke, C. Loddenkemper, A. F. H. Pfeiffer, and M. O. Weickert, “Impairment of fat oxidation under high- vs. low-glycemic index diet occurs before the development of an obese phenotype,” American Journal of Physiology, vol. View at Publisher · View at Google Scholar · View at Scopus - X. Pi-Sunyer, “Do glycemic index, glycemic load, and fiber play a role in insulin sensitivity, disposition index, and type 2 diabetes?” Diabetes Care, vol. View at Publisher · View at Google Scholar · View at Scopus - M. O. Weickert and A. F. H. Pfeiffer, “Low-glycemic index vs high cereal fiber diet in type 2 diabetes,” Journal of the American Medical Association, vol. View at Publisher · View at Google Scholar · View at Scopus - T. M. Wolever, D. J. Jenkins, A. R. Leeds et al., “Dietary fibre and glucose tolerance importance of viscosity,” Proceedings of the Nutrition Society, vol. View at Scopus - L. Brown, B. Rosner, W. W. Willett, and F. M. Sacks, “Cholesterol-lowering effects of dietary fiber: a meta-analysis,” American Journal of Clinical Nutrition, vol. View at Scopus - D. J. A. Jenkins, C. W. C. Kendall, M. Axelsen, L. S. A. Augustin, and V. Vuksan, “Viscous and nonviscous fibres, nonabsorbable and low glycaemic index carbohydrates, blood lipids and coronary heart disease,” Current Opinion in Lipidology, vol. View at Publisher · View at Google Scholar · View at Scopus - M. Chandalia, A. Garg, D. Lutjohann, K. Von Bergmann, S. M. Grundy, and L. J. Brinkley, “Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus,” New England Journal of Medicine, vol. View at Publisher · View at Google Scholar · View at Scopus - N. M. Delzenne and P. D. Cani, “Gut microbiota and the pathogenesis of insulin resistance,” Current Diabetes Reports, vol. View at Publisher · View at Google Scholar · View at Scopus - K. R. Freeland, C. Wilson, and T. M. S. Wolever, “Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects,” British Journal of Nutrition, vol. View at Publisher · View at Google Scholar · View at Scopus - M. O. Weickert, A. M. Arafat, M. Blaut, et al., “Changes in dominant groups of the gut microbiota do not explain cereal-fiber induced improvement of whole-body insulin sensitivity,” Nutrition & Metabolism, vol. View at Publisher · View at Google Scholar - M. Roberfroid, G. R. Gibson, L. Hoyles et al., “Prebiotic effects: metabolic and health benefits,” British Journal of Nutrition, vol. 104, supplement 2, pp. View at Publisher · View at Google Scholar · View at Scopus - M. Blaut and S. Klaus, “Intestinal microbiota and obesity,” Handbook of Experimental Pharmacology, no. 209, pp. 251–273, 2012. - N. M. Delzenne, A. M. Neyrinck, F. Bäckhed, and P. D. Cani, “Targeting gut microbiota in obesity: effects of prebiotics and probiotics,” Nature Reviews Endocrinology, vol. View at Publisher · View at Google Scholar · View at Scopus - F. Isken, S. Klaus, M. Osterhoff, A. F. H. Pfeiffer, and M. O. Weickert, “Effects of long-term soluble vs. insoluble dietary fiber intake on high-fat diet-induced obesity in C57BL/6J mice,” Journal of Nutritional Biochemistry, vol. View at Publisher · View at Google Scholar · View at Scopus - N. S. Track, M. E. Cawkwell, B. C. Chin, S. S. Chiu, S. A. Haberer, and C. R. Honey, “Guar gum consumption in adolescent and adult rats: short- and long-term metabolic effects,” Canadian Journal of Physiology and Pharmacology, vol. View at Scopus - N. I. McNeil, “The contribution of the large intestine to energy supplies in man,” American Journal of Clinical Nutrition, vol. View at Scopus - F. Bäckhed, J. K. Manchester, C. F. Semenkovich, and J. I. Gordon, “Mechanisms underlying the resistance to diet-induced obesity in germ-free mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. View at Publisher · View at Google Scholar · View at Scopus - K. L. Johnston, E. L. Thomas, J. D. Bell, G. S. Frost, and M. D. Robertson, “Resistant starch improves insulin sensitivity in metabolic syndrome,” Diabetic Medicine, vol. View at Publisher · View at Google Scholar · View at Scopus - M. D. Robertson, A. S. Bickerton, A. L. Dennis, H. Vidal, and K. N. Frayn, “Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism,” American Journal of Clinical Nutrition, vol. View at Scopus - M. D. Robertson, J. M. Currie, L. M. Morgan, D. P. Jewell, and K. N. Frayn, “Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects,” Diabetologia, vol. View at Scopus - A. Thorburn, J. Muir, and J. Proietto, “Carbohydrate fermentation decreases hepatic glucose output in healthy subjects,” Metabolism, vol. View at Publisher · View at Google Scholar · View at Scopus - A. L. Garcia, B. Otto, S. C. Reich et al., “Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance,” European Journal of Clinical Nutrition, vol. View at Publisher · View at Google Scholar · View at Scopus - A. L. Garcia, J. Steiniger, S. C. Reich et al., “Arabinoxylan fibre consumption improved glucose metabolism, but did not affect serum adipokines in subjects with impaired glucose tolerance,” Hormone and Metabolic Research, vol. View at Publisher · View at Google Scholar · View at Scopus - A. S. Andreasen, N. Larsen, T. Pedersen-Skovsgaard et al., “Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects,” British Journal of Nutrition, vol. View at Publisher · View at Google Scholar · View at Scopus - C. A. Daubioul, Y. Horsmans, P. Lambert, E. Danse, and N. M. Delzenne, “Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study,” European Journal of Clinical Nutrition, vol. View at Publisher · View at Google Scholar · View at Scopus - Y. Kadooka, M. Sato, K. Imaizumi et al., “Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial,” European Journal of Clinical Nutrition, vol. View at Publisher · View at Google Scholar · View at Scopus - Z. X. Lu, K. Z. Walker, J. G. Muir, and K. O'Dea, “Arabinoxylan fibre improves metabolic control in people with type II diabetes,” European Journal of Clinical Nutrition, vol. View at Publisher · View at Google Scholar · View at Scopus - L. Jing, M. Van Yperselle, S. W. Rizkalla, F. Rossi, F. R. J. Bornet, and G. Slama, “Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics,” Journal of Nutrition, vol. View at Scopus - J. A. Parnell and R. A. Reimer, “Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults,” American Journal of Clinical Nutrition, vol. View at Publisher · View at Google Scholar · View at Scopus - A. Adam, M. A. Levrat-Verny, H. W. Lopez, M. Leuillet, C. Demigné, and C. Rémésy, “Whole wheat and triticale flours with differing viscosities stimulate cecal fermentations and lower plasma and hepatic lipids in rats,” Journal of Nutrition, vol. View at Scopus - M. O. Weickert, M. Mohlig, C. Koebnick et al., “Impact of cereal fibre on glucose-regulating factors,” Diabetologia, vol. View at Publisher · View at Google Scholar · View at Scopus - Y. Granfeldt, X. Wu, and I. Björck, “Determination of glycaemic index; some methodological aspects related to the analysis of carbohydrate load and characteristics of the previous evening meal,” European Journal of Clinical Nutrition, vol. View at Publisher · View at Google Scholar · View at Scopus - A. Lammert, J. Kratzsch, J. Selhorst et al., “Clinical benefit of a short term dietary oatmeal intervention in patients with type 2 diabetes and severe insulin resistance: a pilot study,” Experimental and Clinical Endocrinology and Diabetes, vol. View at Publisher · View at Google Scholar · View at Scopus - A. Nilsson, Y. Granfeldt, E. Östman, T. Preston, and I. Björck, “Effects of GI and content of indigestible carbohydrates of cereal-based evening meals on glucose tolerance at a subsequent standardised breakfast,” European Journal of Clinical Nutrition, vol. View at Publisher · View at Google Scholar · View at Scopus - R. A. Samra and G. H. Anderson, “Insoluble cereal fiber reduces appetite and short-term food intake and glycemic response to food consumed 75 min later by healthy men,” American Journal of Clinical Nutrition, vol. View at Scopus - K. Rave, K. Roggen, S. Dellweg, T. Heise, and H. tom Dieck, “Improvement of insulin resistance after diet with a whole-grain based dietary product: results of a randomized, controlled cross-over study in obese subjects with elevated fasting blood glucose,” British Journal of Nutrition, vol. View at Publisher · View at Google Scholar · View at Scopus - M. A. Pereira, D. R. Jacobs Jr., J. J. Pins et al., “Effect of whole grains on insulin sensitivity in overweight hyperinsulinemic adults,” American Journal of Clinical Nutrition, vol. View at Scopus - M. O. Weickert, M. Möhlig, C. Schöfl et al., “Cereal fiber improves whole-body insulin sensitivity in overweight and obese women,” Diabetes Care, vol. View at Scopus - K. E. Ferrier, P. Nestel, A. Taylor, B. G. Drew, and B. A. Kingwell, “Diet but not aerobic exercise training reduces skeletal muscle TNF-a in overweight humans,” Diabetologia, vol. View at Publisher · View at Google Scholar · View at Scopus - V. Regitz-Zagrosek, E. Lehmkuhl, and M. O. Weickert, “Erratum: gender differences in the metabolic syndrome and their role for cardiovascular disease,” Clinical Research in Cardiology, vol. View at Publisher · View at Google Scholar · View at Scopus - A. J. Stull, J. E. Galgani, W. D. Johnson, and W. T. Cefalu, “The contribution of race and diabetes status to metabolic flexibility in humans,” Metabolism, vol. View at Publisher · View at Google Scholar · View at Scopus
1.1 2.1 3.1 3.2 4.1 5.1 5.2 5.3 6.1 6.2 7.1 8.1 8.2 8.3 8.4 9.1 10.1 11.1 12.1 13.1 14.1 15.1 15.2 15.3 15.4 15.5 16.1 17.1 18.1 19.1 19.2 20.1 21.1 21.2 21.3 22.1 22.2 22.3 23.1 24.1 24.2 25.1 26.1 27.1 28.1 28.2 28.3 29.1 29.2 29.3 29.4 30.1 31.1 32.1 33.1 33.2 34.1 34.2 35.1 36.1 37.1 38.1 39.1 40.1 41.1 41.2 41.3 41.4 42.1 43.1 43.2 44.1 45.1 46.1 47.1 47.2 47.3 47.4 47.5 47.6 48.1 48.2 49.1 49.2 50.1 50.2 50.3 51.1 51.2 52.1 52.2 52.3 52.4 53.1 53.2 53.3 54.1 54.2 55.1 56.1 57.1 58.1 58.2 59.1 59.2 59.3 60.1 60.2 61.1 61.2 62.1 62.2
Iva Jirka Alebić, Darija Vranešić Bender preuzeto s Plivamed.net Metabolički sindrom predstavlja skupinu metaboličikih nepravilnosti koje povećavaju rizik za razvoj kardiovaskularnih bolesti, te dijabetesa tipa 2. Pojedina stanja koja definiraju metabolički sindrom uključuju aterogenu dislipidemiju, povišen krvni tlak, povišenu razinu glukoze u plazmi i/ili inzulinsku rezinstenciju, abdominalnu pretilost te, tek nedavno prepoznato, proinflamatorno i protrombotičko stanje. Što je metabolički sindrom? Zbog potrebe za internacionalno standardiziranom definicijom metaboličkog sindroma, Internacionalna dijabetička federacija (International Diabeic Federation) je predložila definiciju za opću uporabu. Prema njoj, metabolički sindrom je definiran središnjom pretilošću, koja je pak definirana obimom struka specifičnim za dob i etničku pripadnost, uz prisutnost dvije od četiri navedene komponente: povišene koncentracije triglicerida (≥1,7mmol/l ili ≥150 mg/dcl), niske razine HDL kolesterola (<1,03mmol/l ili <40mg/dcl kod muškaraca te <1,03mmol/l ili <50mg/dcl kod žena), povišenog krvnog tlaka (sistolički, ≥130 ili dijastolički ≥85 mmHg) te povišene razine glukoze u plazmi (≥5,6mmol/l ili ≥100 mg/dcl, ili prethodno dijagnosticiran dijabetes tipa 2). Dodatne komponente, za koje su potrebna daljnja istraživanja i definiranja uključuju proinflamatorna i protrombotička stanja.(1) Točna etiologija nastanka metaboličkog sindroma još uvijek je nejasna, no poznato je da uključuje kompleksnu interakciju genetičkih, metaboličkih te čimbenika iz okoliša. Među čimbenicima iz okoliša, glavnu važnost u prevenciji i terapiji ovoga stanja ima adekvatna prehrana. Nutritivna terapija metaboličkog sindroma Terapija metaboličkog sindroma ciljano je usmjerena ka poboljšanju osjetljivosti na inzulin te prevenciji i „popravljanju" pridruženih metaboličkih i kardiovaskularnih nepravilnosti. (2) S tim u vezi, nutritivna terapija uključuje smanjenje i održavanje tjelesne mase, tjelesnu aktivnost te adekvatni prehrambeni model. I upravo primjerena nutritivna terapija može rezultirati simultanim smanjenjem svih metaboličkih čimbenika rizika. (3) Važno je ipak naglasiti da, i bez obzira što nutritivna terapija osoba s metaboličkim sindromom ima neke zajedničke opće karakteristike, ona također mora biti specijalno isplanirana tako da uzme u obzir prisutne metaboličke nepravilnosti kod pojedinog pacijenta. Opće karakteristike nutritivne terapije osoba sa metaboličkim sindromom Opće karakteristike nutritivne terapije osoba sa metaboličkim sindromom su: (4) • Postaviti realne ciljeve gubitka tjelesne mase; kod osoba sa prekomjernom tjelesnom masom i pretilih osoba cilj je smanjenje tjelesne mase za 7 - 10%, a potom održavanje postignute mase • Prosječno 6-7 serviranja žitarica dnevno, od toga barem 3 serviranja cjelovitih žitarica; potaknuti unos 20-35 grama prehrambenih vlakana na dan • Smanjiti unos zasićenih masnoća na  • Poticati redovitu tjelesnu aktivnost; 30-60 minuta umjerene aerobne aktivnosti dnevno te trening izdržljivosti 2 puta tjedno. Povišena tjelesna masa i pretilost Smanjenje prekomjerne tjelesne mase primarna je intervencija u prevenciji i terapiji metaboličkog sindroma. I mali gubitak tjelesne mase, poput 5%-tnog, rezultirat će značajnim poboljšanjem zdravstvenoga statusa. Osjetljivost na inzulin, zahvaljujući metabolizmu glukoze, rapidno se popravlja već na samom početku provođenja hipokalorijske dijete, odnosno, puno prije nego dođe do gubitka tjelesne mase. Sistolički i dijastolički tlak smanjuju se proporcionalno smanjenju tjelesne mase, cirkulirajući markeri upale, uključujući C-reaktivni protein i citokine, smanjuju se gubitkom adipoznog tkiva, a razine serumskih triglicerida i LDL kolesterola popravljaju se tijekom prva dva mjeseca od gubitka suvišne tjelesne mase. Ipak, čini se da je za održavanje smanjenja razine triglicerida, potreban gubitak tjelesne mase ≥5%, te da se razine ukupnog i LDL kolesterola vraćaju u prvotni stadij ukoliko se ne osigura gubitak tjelesne mase ≥10%. Planiranje prehrane s obzirom na prisutne metaboličke nepravilnosti Danas su DASH dijeta uz preporuke o smanjenom unosu soli najčešće predlagane nutritivne intervencije za sniženje povišenog krvnog tlaka. Hipertenzijama Promjene prehrambenih navika u smislu smanjenja kalorijskog unosa, smanjenja unosa soli te smanjenje unosa alkohola primarne su nutritivne intervencije usmjerene ka snižavanju povišenog tlaka te prevenciji hipertenzije. Revizijom prospektivnih studija i kliničkih pokusa utvrđeno je da, kod osoba s prekomjernom tjelesnom masom te pretilih osoba, svaki gubitak od oko 10 kilograma rezultira smanjenjem sistoličkog tlaka za 6 mmHg te dijastoličkog za 4,6 mmHg. DASH dijeta u liječenju hipertenzije Opće prihvaćen prehrambeni model usmjeren ka smanjenju povišenog krvnog tlaka je tzv. DASH dijeta (Dietary Approaches to Stop Hypertension - Svladavanje hipertenzije prehranom). Dijeta se temelji na visokom unosu voća i povrća, cjelovitih žitarica, niskomasnih mliječnih proizvoda te ograničenju suhomesnatih proizvoda . Studijom koja je trajala 11 tjedana pokazano je da DASH dijeta rezultira smanjenjem sistoličkog tlaka za 5,5 mmHg te dijastoličkog tlaka za 3 mmHg u odnosu na kontrolnu prehranu (prehrana koja je predstavljala prosječan unos makro i mikronutrijenata te prehrambenih vlakana u svakodnevnoj prehrani Amerikanaca). (6) Također je utvrđeno da ovaj model prehrane može imati pozitivan utjecaj i na osobe normalnim vrijednostima krvnog tlaka što ukazuje na potencijalno preventivnu ulogu DASH dijete. Blagotvorno djelovanje DASH dijete objašnjava se kroz povećanje antioksidativnog kapaciteta i smanjenje oksidativnog stresa povezanih sa hiperlipidemijom kod pretilih hipertenzitivnih osoba. Smanjenje unosa soli) Postoje uvjerljivi dokazi prema kojima se smanjenjem unosa soli može postići i smanjenje povišenog krvnog tlaka. U meta-analizi iz 2002. godine pokazano je da smanjenje dnevnog unosa soli za 6 g rezultira značajnim sniženjem sistoličkog i dijastoličkog tlaka, kako kod osoba sa povišenim krvnim tlakom (za 7,11/3,88 mmHg) tako i kod osoba sa normalnim krvnim tlakom (za 3,57/1,56 mmHg). Danas su DASH dijeta uz preporuke o smanjenom unosu soli najčešće predlagane nutritivne intervencije za sniženje povišenog krvnog tlaka. Osjetljivost na inzulin Na osjetljivost na inzulin može utjecati kako ukupan energetski unos, tako i sastav prehrane. Brojne dostupne epidemiološke studije pokazale su da je unos masti povezan i s vrijednostima inzulina u plazmi i s osjetljivošću na inzulin. S tim u vezi, od posebne važnosti pokazala se kvaliteta prehrambenih masnoća. Tako su rezultati studija pokazali da povišen unos zasićenih masnoća rezultira smanjenjem osjetljivosti na inzulin, dok unos omega-3 i jednostruko nezasićenih masnih kiselina utječe na poboljšanje osjetljivosti na inzulin. Pitanje optimalne količine i izvora ugljikohidrata s ciljem poboljšanja osjetljivosti na inzulin još uvijek je otvoreno s obzirom da su rezultati provedenih studija u nesuglasju. Uobičajena pretpostavka da visok unos ugljikohidrata i/ili šećera doprinosi inzulinskoj rezistenciji čini se ne stoji. Veza između unosa ugljikohidrata te biomarkera kontrole glikemije ispitivana je na reprezentativnom uzorku zdravih odraslih osoba koje su sudjelovale u NHANES III (National Health and Nutrition Examination Survey) istraživanju. Rezultati su pokazali da unos ugljikohidrata, bilo visok ili nizak, nije utjecao na razinu glukoze u plazmi ili koncentraciju inzulina u serumu, niti kod žena niti kod muškaraca, čak i kada su u obzir uzeti drugi mogući čimbenici rizika. Epidemiološke studije nisu donijele dovoljno dokaza na osnovu kojih bi se zaključilo da ukupan unos ugljikohidrata može predvidjeti rizik od dijabetesa tipa 2, naprotiv, sve više je studija koje su pokazale da prehrana koju karakterizira visok unos ugljikohidrata i prehrambenih vlakana, te odabir namirnica s niskim glikemijskim indeksom, može poboljšati funkciju beta-stanica kod osoba sa narušenom tolerancijom na glukozu te stoga može biti korisna u terapiji istih. Dislipidemija Metabolizam glukoze i lipida usko su povezani te svako remećenje metabolizma ugljikohidrata potaknuto visokim unosom istih može rezultirati porastom razine triglicerida te smanjenjem razine HDL kolesterola, što je pokazano i meta-analizama studija koje su uspoređivale prehranu bogatu jednostruko nezasićenim masnim kiselinama te prehranu bogatu ugljikohidratima. Podaci prikupljani u NHANES III istraživanju korišteni su i u svrhu utvrđivanja unosa ugljikohidrata i rizika od kardiovaskularnih bolesti. Uočeno je da povišen unos ugljikohidrata (ugljikohidrati osiguravaju >57% ukupno unesene energije) uzrokuje smanjenje razine HDL kolesterola te povećanje razine triglicerida. Međutim, s druge strane je umjeren unos ugljikohidrata (ugljikohidrati osiguravaju 50-55% ukupno unesene energije) povezan s manjim rizikom od kardiovaskularnih bolesti te sa poželjnim lipidnim profilom. Nadalje, većina osoba dnevno vrlo rijetko unosi količinu ugljikohidrata koja bi osigurala više od 55% ukupne energije pa je samim time i realna opasnost od porasta triglicerida usljed opisanog načina prehrane u općoj populaciji vrlo mala. Povišen unos prehrambenih vlakana kao i omega-3 masnih kiselina pokazao se blagotvornim i kad je riječ o lipidnom profilu. Tako je, primjerice, pokazano da povišen unos prehrambenih vlakana, i bez drugih promjena prehrambenih navika, može rezultirati smanjenjem kolesterola za 2 - 4 %, kao i da dnevni unos 25 - 30 g prehrambenih vlakana, može rezultirati smanjenjem razine kolesterola za čak 12 %. Kada je riječ o omega-3 masnim kiselinama, brojne studije iznjedrile su snažne dokaze prema kojima ove vrste masnih kiselina uspješno i bez neželjenih nuspojava snižavaju razinu triglicerida i kolesterola te poboljšavaju omjer HDL i LDL kolesterola. Prema rezultatima randomizirane studije u kojoj je sudjelovalo 46 osoba sa koronarnom bolešću srca, suplementacija omega-3 masnim kiselinama rezultirala je smanjenjem triglicerida u serumu za 20-30%, te smanjenjem razine VLDL kolesterola za 30-40%. Mediteranska prehrana – najbolja dijeta kod metaboličkog sindroma Mediteranska prehrana u cijelosti, kao i njene pojedine komponente, posebice maslinovo ulje, voće i povrće, žitarice i riba, dokazano pružaju značajno antioksidativno i protuupalno djelovanje koje može pomoći u borbi protiv bolesti povezanih sa kroničnim upalama, uključujući pretilost, dijabetes tipa 2 te metabolički sindrom. Utjecaj mediteranske prehrane na metabolički sindrom praćen je i pozitivno ocijenjen u velikom broju znanstvenih studija. Jedna od njih i i velika Framingham Heart Study Offspring Cohort, u kojoj su analizirani podaci oko 5000 osoba. U studiji se dosljednost mediteranskom tipu prehrane utvrđivala putem Mediterranean-style dietary pattern score (MSDPS), a rezultati su pokazali da je viši MSDPS povezan sa nižom HOMA vrijednosti (homeostatic model assessment - mjera osjetljivosti na inzulin i funkciju beta stanica) - P= 0.02; manjim opsegom struka - P= 0.001; nižom razinom glukoze u plazmi tijekom gladovanja - P= 0.03; nižom razinom triglicerida - P= 0.001 te višom razinom HDL kolesterola - P= 0.03. Također, sudionici sa najvišim MSDPA (gornja kvintila) imali su manji rizik za razvoj metaboličkog sindroma u odnosu na sudionike sa najnižim MSDOA (najniža kvintila) - P= 0.01. Vrlo ohrabrujuća studija objavljena je nedavno u Journal of the American College of Cardiology, a prema njoj, mediteranska prehrana ima blagotvorno djelovanje, ne samo na metabolički sindrom, već i na pojedinačne komponente (stanja) metaboličkog sindroma - opseg struka, razinu HDL kolesterola i triglicerida, krvni tlak te metabolizam glukoze. Ova studija je meta-analiza 50 studija, objavljenih između 1994. i 2010. koje su proučavale djelovanje mediteranske prehrane, a u njima je sudjelovalo ukupno 500 000 osoba. Prema podacima 35 studija, ova vrsta prehrane povezana je s prosječnim smanjenjem opsega struka za 0,43 cm, porastom razine HDL kolesterola za 1,17 mg/dcl, sniženjem razine triglicerida za 6,14 mg/dcl, sistoličkog i dijastoličkog tlaka za 2,35 odnosno 1,58 mm/Hg, razine glukoze u fazi gladovanja za 3,89 mg/dcl te HOMA-e za 0,45. Mediteransku prehranu karakterizira visok unos jednostrukonezasićenih masnih kiselina, prvenstveno iz maslina i maslinovog ulja, dnevna konzumacija voća, povrća, cjelovitih žitarica, niskomasnih mliječnih proizvoda, tjedna konzumacija ribe, mesa peradi, orašastih plodova i mahunarki, relativno nizak unos crvenog mesa te umjerena dnevna konzumacija crnog vina, uglavnom uz obroke. Kako navode autori posljednje objavljene meta-analize, a njihov zaključak neka bude i zaključak ovoga članka, predočeni rezultati značajni su za ukupno javno zdravstvo jer mediteransku prehranu vrlo lako mogu slijediti razne populacijske skupine i različite kulture, ne iziskuje mnogo novca, a mnogo sredstava može uštedjeti zdravstvu jer je dokazano djelotvorna kod primarne i sekundarne prevencije metaboličkog sindroma i njegovih pojedinačnih komponenata. Literatura Alberti, P. Zimmet, J. Shaw. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Medicine 2006; 23(5): 469-480 - Gabriele Riccardi* and A. Rivellese, Dietary treatment of the metabolic syndrome - the optimal diet, British Journal of Nutrition (2000), 83, Suppl. 1, S143-S148 - Marion J. Franz,The Role of Nutrition Therapy and Dietitians in the Management of the Metabolic Syndrome, Current Diabetes Reports 2007, 7:60-65 - Grundy SM, Cleeman JI, Daniels SR, et al.: Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive Summary. - Klein S, Burke LE, Bray GA, et al.: Clinical implications of obesity with specific focus on cardiovascular disease. A statement for professionals from the American Heart Association - Feldeisen SE, Tucker KL. Nutritional strategies in the prevention and treatment of metabolic syndrome. Appl Physiol Nutr Metab. 2007 Feb;32(1):46-60. Council on Nutrition, Physical Activity, and Metabolism. - Heno F. Lopes; et al. DASH Diet Lowers Blood Pressure and Lipid-Induced Oxidative Stress in Obesity; Hypertension. 2003;41:422-430 - He FJ, MacGregor GA.Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. - Riccardi G, Giacco R, Rivellese AA.Dietary fat, insulin sensitivity and the metabolic syndrome.Clin Nutr. 2004 Aug;23(4):447-56. - Wolever TM, Mehling C.High-carbohydrate-low-glycaemic index dietary advice improves glucose disposition index in subjects with impaired glucose tolerance. - Yang EJ, Chung HK, Kim WY, et al.: Carbohydrate intake and biomarkers on glycemic control among US adults: the third National Health and Nutrition Examination Study (NHANES III). - Yang EJ, Chung HK, Kim WY, et al.: Carbohydrate intake is associated with diet quality and risk factors for cardiovascular disease in US adults: NHANES III. J Am Coll Nutr 2002, 22:71-79. - Bazzano LA, et al. Dietary fiber intake and reduced risk of coronary heart disease in U.S. men and women. Archives of Internal Medicine, 63(16): 1897-1904. - Durrington PN, Bhatnagar D, Mackness MI, Morgan J, Julier K, Khan MA, France M. An omega-3 polyunsaturated fatty acid concentrate administered for 1 year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridemia. - Marcella E Rumawas et.al. Mediterranean-style dietary pattern, reduced risk of metabolic syndrome traits, and incidence in the Framingham Offspring Cohort. - Christina-Maria Kastorini, et.al. The Effect of Mediterranean Diet on Metabolic Syndrome and its Components.